The QualityStocks Daily Wednesday, April 26th, 2023

Today's Top 3 Investment Newsletters

QualityStocks(CRKN) $0.1519 +80.19%

MarketClub Analysis(SAI) $3.7400 +34.26%

MarketBeat(PBLA) $0.5600 +33.33%

The QualityStocks Daily Stock List

Crown Electrokinetics (CRKN)

QualityStocks, AwesomeStocks, StockStreetWire, StockEarnings, Small Cap Firm, Fierce Analyst, Zacks, The Stock Dork, StockWireNews, Mega Stock Alerts and Early Bird reported earlier on Crown Electrokinetics (CRKN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Crown ElectroKinetics Corp (NASDAQ: CRKN) is focused on the commercialization of electrokinetic technology.

The firm has its headquarters in Corvallis, Oregon and was incorporated in 2015, on April 20th by Timothy Koch, James Douvikas and Douglas B. Croxall. Prior to its name change in October 2017, the firm was known as 3D Nanocolor Corp. The firm serves consumers in the United States.

The enterprise develops and sells optical switching film which can be applied to the surface of glass or other rigid substrates like acrylic, to control opacity electronically. The film can also be embedded between sheets of smart glass powered by solar strips. The enterprise’s electro kinetic film technology, which is derived from microfluidic and ink technology, uses nanometer-sized particles of pigments which have been charged electrically and suspended in a liquid sandwiched between substrates coated with a transparent conductor oxide film. The film enables transitions between dark and clear, which allows individuals to prevent and/or manage glare, control the tint of the skylight, block out ultraviolet rays, decrease carbon emissions, and decrease the amount of heat entering the home. The enterprise’s offerings can be applied to a range of windows, including automotive sunroofs, residential windows and skylights and commercial buildings.

The company recently entered into an agreement with Hudson Pacific Properties, which involves the installation of energy-saving smart window inserts at some of the properties Hudson owns on the West Coast. This move will not only help Hudson Pacific reduce carbon emissions and energy consumption from cooling and heating systems by at least 25%, but also bring in additional revenue to Crown Electrokinetics and help extend the company’s consumer reach.

Crown Electrokinetics (CRKN), closed Wednesday's trading session at $0.1519, up 80.1898%, on 282,767,579 volume. The average volume for the last 3 months is 13.438M and the stock's 52-week low/high is $0.05/$1.36.

Elevation Oncology (ELEV)

Actual Gains, QualityStocks, PennyStockRumors.net, OTCPicks, Buzz Stocks, FeedBlitz, HEROSTOCKS, Liquid Pennies, MarketBeat, Money Wealth Matters, PennyTrader Publisher, WhisperFromWallStreet, SmallCapStockPlays, Stock Brain, Stock Exploder, Stockhunter.us, The Night Owl, VIP STOCK ALERTS and Otcstockexchange reported earlier on Elevation Oncology (ELEV), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Elevation Oncology Inc. (NASDAQ: ELEV) is a clinical-stage biopharmaceutical firm that is engaged in the development of therapeutics for treating cancer in genomically-defined patient populations.

The firm has its headquarters in New York and was incorporated in 2019 by Shawn M. Leland. It serves consumers in the United States.

The company’s objective is to introduce new targeted therapies for patients with cancer as well as illuminate what the company is doing to create a future where every patient can receive care built around targeting their unique tumor drivers and understanding. This will be done by having every tumor’s unique genomic test result matched with a purpose-built precision medicine that will allow the use of individualized treatment plans for patients.

The enterprise’s formulations identify and target inhibition of tumor-specific drive alterations. Its product portfolio comprises of an anti-HER3 monoclonal antibody dubbed seribantumab, which is undergoing a phase 2 Crestone trial evaluating its effectiveness in treating advanced solid tumors that harbor neuregulin-1 fusions (NRG1 fusions).The NRG1 gene fusions are rare genomic alterations which combine NRG1 with other partner proteins to create a chimeric NRG1 fusion protein. These fusions have been identified in a variety of solid tumors, including cholangio carcinomas, neuroendocrine, colorectal, ovarian, breast, gallbladder, pancreatic, lung and sarcomas.

The firm is focused on making progress on its mission to bring purpose-built medicines to patients suffering from genomically defined cancers. The success of their formulations will not only address unmet needs in patients but also bring in more investments into the firm.

Elevation Oncology (ELEV), closed Wednesday's trading session at $3.03, up 77.193%, on 13,437,811 volume. The average volume for the last 3 months is 88,877 and the stock's 52-week low/high is $0.7229/$4.6099.

Flux Power (FLUX)

QualityStocks, MarketBeat, PennyStocks24, Greenbackers, StreetInsider, Marketbeat.com, Wall Street Grand, Joe Penny Stocks, Lebed.biz, Liquid Tycoon, WePickPennyStocks, Penny Stock Pick Alert, Penny Stock Pick Report, PennyPickAlerts, PoliticsAndMyPortfolio, Catalyst IR, TopPennyStockMovers, Winning Penny Stock Picks, RisingPennyStocks, Stock News Now, StockMister, Super Hot Penny Stocks, Super Nova Stock Picks, The Wall Street Transcript, Tip.us and PennyStockMoneyTrain reported earlier on Flux Power (FLUX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Flux Power Holdings Inc. (NASDAQ: FLUX) is focused on designing, developing, manufacturing and selling lithium-ion energy storage solutions for airport ground support equipment, lift trucks, solar applications and robotic applications, as well as other commercial and industrial applications.

The firm has its headquarters in Vista, California and was incorporated in 1998, on September 21st by Michael Johnson and Christopher L. Anthony. It operates as part of the electrical equipment and parts industry, under the industrials sector. The firm serves consumers in the United States.

The company is focused on providing Li-ion energy storage solutions that help improve sustainability and ESG metrics for fleets while decreasing carbon dioxide emissions. It operates through its Flex Power Inc. subsidiary. The company offers its customers more environmentally friendly and better performing alternatives to traditional solutions.

The enterprise provides battery management systems that offer cell charging, balancing, discharging, monitoring and communication between the forklift and the pack. It also offers smart wall-mounted chargers to interface with battery management systems; and 24-volt onboard chargers for its class 3 Walkie LiFT packs. The enterprise sells its products directly to small firms and end-users, as well as through battery distributors, lift equipment dealers and original equipment manufacturers.

The firm’s recently released financial results show significant increases in its revenue and consumer purchase orders. It remains focused on increasing sales of its solutions to existing and new customers and meeting consumer demand. This will continue to drive its revenues and bolster the firm’s overall growth.

Flux Power (FLUX), closed Wednesday's trading session at $3.43, up 13.2013%, on 91,874 volume. The average volume for the last 3 months is 2.935M and the stock's 52-week low/high is $1.8901/$7.50.

Selecta Biosciences (SELB)

MarketBeat, StreetInsider, StockMarketWatch, TraderPower, Kiplinger Today, TradersPro, The Street, MarketClub Analysis, InvestorPlace, BUYINS.NET, Barchart, Trading Concepts and QualityStocks reported earlier on Selecta Biosciences (SELB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Selecta Biosciences Inc. (NASDAQ: SELB) (FRA: 1S7) is a clinical stage biopharmaceutical firm that is engaged in the research and development of nanoparticle immunomodulatory medications for preventing and treating various ailments.

The company is based in Watertown, Massachusetts and was incorporated in 2007, by Ulrich von Andrian, Robert S. Langer Jr. and Omid C. Farokhzad. It operates in the United States and develops the synthetic vaccine particles platform for immune stimulation and immune tolerance.

The firm is party to collaboration and license agreements with IGAN Biosciences Inc., Sarepta Therapeutics Inc., Asklepios BioPharmaceutical Inc., Shenyang Sunshine Pharmaceutical Co. Ltd, Massachusetts Institute of Technology, Spark Therapeutics and Swedish Orphan Biovitrum.

Its proprietary pipeline is made up of gene therapies, enzyme therapies and other candidates which are affected by undesired immune responses. Selecta Biosciences’ products include SEL-212, which is currently in phase 3 clinical trials for treating chronic refractory gout as well as another candidate indicated for the treatment of IgA-mediated ailments, which include IgA vasculitis, IgA pemphigus, linear IgA bullous dermatitis and IgA nephropathy. In addition, it also develops a gene therapy candidate for treating methylmalonic acidemia, dubbed MMA-101; a candidate indicated for the treatment of ornithine transcarbamylase deficiency, known as SEL-313 and another that’s indicated for the reduction of antibody formation to AAV capsids, dubbed SEL-399. The company is also engaged in the development of a candidate for the treatment of primary biliary cholangitis.

The enterprise recently obtained exclusive rights to its MMA program, which strengthens its fully-owned gene therapy portfolio. This will allow them to independently advance the program through clinical development, which is bound to bring in more investors.

Selecta Biosciences (SELB), closed Wednesday's trading session at $1.17, up 12.5%, on 2,943,441 volume. The average volume for the last 3 months is 3.047M and the stock's 52-week low/high is $0.6469/$2.73.

Rolls-Royce Holdings (RYCEY)

MarketBeat, Real Pennies, Daily Trade Alert, Trades Of The Day, The Street, InvestorPlace, Marketbeat.com, Kiplinger Today, MarketClub Analysis, Zacks, Money and Markets, Barchart, Market Authority, Investors Alley, StockOodles, Investing Daily and StreetInsider reported earlier on Rolls-Royce Holdings (RYCEY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Rolls-Royce Holdings Plc (OTC: RYCEY) (LON: RR) (FRA: RRU) is an industrial technology firm that is focused on designing, developing, manufacturing and servicing integrated power systems for use on land, at sea or in the air.

The firm has its headquarters in London, the United Kingdom and was incorporated in 1884. It operates as part of the aerospace and defense industry, under the industrials sector. The firm serves consumers around the globe, with a focus on those in the United Kingdom.

The company operates through the Civil Aerospace, Power systems, Defense and New Markets segments. The Civil Aerospace segment is focused on developing, manufacturing, marketing and selling aero engines for large commercial aircraft, regional jet, and business aviation markets. It also offers aftermarket services. The Power Systems segment develops, manufactures, markets and sells integrated solutions for onsite power and propulsion for the defense, marine, power generation, and industrial markets. The Defense segment is involved in the development, manufacture, marketing, and sale of military naval engines, aero engines, and submarine nuclear power plants. It also provides aftermarket services. The New Markets segment is engaged in the development, manufacture and sale of small modular reactor and new electrical power solutions. In addition to this, the company offers maintenance, repair, and overhaul services.

The enterprise, whose latest financial results show increases in its revenues, remains focused on prioritizing investment towards profitable opportunities. This will bolster the enterprise’s overall growth while also creating value for its shareholders.

Rolls-Royce Holdings (RYCEY), closed Wednesday's trading session at $1.85, up 0.543478%, on 3,052,299 volume. The average volume for the last 3 months is 294,841 and the stock's 52-week low/high is $0.711/$1.91.

Regenx Tech (RGXTF)

We reported earlier on Regenx Tech (RGXTF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Regenx Tech Corp (OTC: RGXTF) (FRA: J64) is a mining firm focused on exploring for and developing mineral properties as well as developing and deploying extraction technologies.

The firm has its headquarters in St. Albert, Canada and was incorporated in 2017. Prior to its name change in October 2022, the firm was known as Mineworx Technologies Limited. It operates as part of the other precious metals and mining industry, under the basic materials sector. The firm serves consumers across the globe.

The company has two operating segments; exploration, and development of mineral properties in Spain and mineral extraction through use of its equipment in North America. Its subsidiaries include SME Resources Ltd. and Solid Mines Espana, S.A.U.

The enterprise has an option acquire interest in the Aroche Wollastonite Project, which comprises of 5 mining grids that cover roughly 150 hectares, located in the province of Huelva, southwestern Spain. It also develops HM X-mill, a mineral grinding mill for grinding of ores, as well as regrinding of concentrates and tailings; HM X-tract, a modular turnkey portable processing unit that includes crushing, grinding, sizing, gravity separation, floatation, concentration, clarification, water recycling, power generation, and operational service support modules; and HM X-leach, a cyanide-free process for the extraction of gold and other precious metals.

The firm, which recently launched its first cleantech facility in Tennessee, is positioned for growth in the tech sector through the development and commercialization of its environmentally friendly processing technologies for the recovery of precious metals, a move that will bring in investments into the firm while also generating shareholder value.

Regenx Tech (RGXTF), closed Wednesday's trading session at $0.0925, up 5.3531%, on 294,841 volume. The average volume for the last 3 months is 9,786 and the stock's 52-week low/high is $N/A/$N/A.

GoLogiq (GOLQ)

Emerging Markets reported earlier on GoLogiq (GOLQ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

GoLogiq Inc. (OTC: GOLQ) is a technology firm engaged in the provision of solutions that offer access and reduce transaction friction of e-commerce for small-to-medium-sized businesses globally.

The firm has its headquarters in New York, the United States and was incorporated in 2004, on November 16th. It operates as part of the software-application industry, under the technology sector. The firm serves consumers around the globe.

The company operates through the DataLogiq and AppLogiq segments. The DataLogiq segment offers generation and e-commerce marketing solutions across vertical industries that include insurance, home repair and mortgage lending. It also provides a holistic, self-serve e-commerce marketing platform. On the other hand, the AppLogiq segment allows small and medium sized businesses to create and deploy a native mobile app for their business without technical knowledge or background. AppLogiq empowers businesses to increase sales, reach customers, promote their products and services and manage logistics.

The enterprise’s offerings include the CreateApp, a Platform as a Service (PaaS) that allows to create mobile apps for their business; Gologiq, a PaaS platform that offers mobile payment capabilities for the local food delivery service industry; and Paylogiq, an e-wallet that supports the PaaS strategy of the CreateApp platform.

The company recently appointed a new Chief Marketing Officer who has decades of experience in sales, marketing, strategic planning, business development and operations. This move will drive the company’s growth while also providing great marketing insights and contributions as the company expands its growing Fintech ecosystem organically and through strategic acquisitions.

GoLogiq (GOLQ), closed Wednesday's trading session at $2.75, off by 5.1724%, on 9,786 volume. The average volume for the last 3 months is 610,754 and the stock's 52-week low/high is $1.30/$7.09.

CYIOS Corp (CYIO)

Bull in Advantage, OtcWizard, OTCPicks, Real Pennies, Nebula Stocks, Liquid Tycoon, Super Hot Penny Stocks, PennyStocks24, Super Nova Stock Picks, Penny Stock Pick Alert, QualityStocks, Winning Penny Stock Picks, HyperSpeedStocks, WePickPennyStocks, Penny Stock Pick Report, LevelStock, Penny Stock MoneyTrain, OTC Advisors, Penny Stock Rumble, Purely Penny Stocks, ShamrockStocks, SteroidStocks, StockMister, StockRod, Stratospheric Stocks, UltimatePennyStock and PennyStockMoneyTrain reported earlier on CYIOS Corp (CYIO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

CYIOS Corporation (OTC: CYIO) is a holding firm focused on building a one stop shop crypto platform.

The firm has its headquarters in Deerfield Beach, Florida and was incorporated in 1994 by Timothy W. Carnahan. It operates as part of the credit services industry, under the financial services sector. The firm serves consumers around the globe.

The company looks to develop, distribute, and license proprietary products as well as evaluate potential acquisition opportunities. It continues to seek and evaluate attractive business opportunities and leverage its resources and expertise to build a diversified, sustainable business model. The company’s subsidiary businesses including Helio Exchange, Helio Lending, Immortals Group Pty Ltd, Choice Wellness Inc. and Randombly.

The enterprise’s crypto platform encompasses crypto-currency lending through Helio's centralized finance (CeFi) Aggregator platform, Crypto trading through Helio Exchange, non-fungible token (NFT) minting and trading through Randombly NFT Marketplace, design, produce, market, sell collections of NFTs though Immortals group; and Choice Wellness, which is focused on developing and marketing specialty branded products in the Health and Wellness markets, including the DR's CHOICE and 24 brands of products. Randombly is an NFT Platform enabling minting and trading of NFT's utilizing Ethereum ERC721 & ERC1155 smart contracts, enabling artists, investors, and collectors to mint, auction, and house their digital art, all in one place.

The company, which recently gave an update on its operations, remains focused on delivering returns to its shareholders while also growing in the financial sector.

CYIOS Corp (CYIO), closed Wednesday's trading session at $0.01435, off by 4.3333%, on 610,754 volume. The average volume for the last 3 months is 22 and the stock's 52-week low/high is $0.0079/$0.069.

Zoned Properties (ZDPY)

MarketBeat, TheMicrocapNews, Stockgoodies, Promotion Stock Secrets, Money Morning, Marketbeat.com and CFN Media Group reported earlier on Zoned Properties (ZDPY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Zoned Properties Inc. (OTCQB: ZDPY) is a real estate development company for emerging and regulated industries like legalized cannabis, focused on owning, developing, operating and leasing a portfolio of commercial properties.

The firm has its headquarters in Scottsdale, Arizona and was incorporated in 2003, on August 25th. Prior to its name change in October 2013, the firm was known as Vanguard Minerals Corporation. It operates as part of the real estate services industry, under the real estate sector. The firm primarily serves clients in the United States.

The company is focused on identifying and developing commercial properties that intend to operate within regulated industries, including the regulated and legalized cannabis industry. It operates through the Property Investment Portfolio and Real Estate Services segments. The Property Investment Portfolio segment is focused on the leasing and management of its leased commercial properties. On the other hand, the Real Estate Services segment is engaged in the advisory and brokerage services related to commercial properties.

The enterprise leases land and/or building space at all four of the properties in its portfolio. The properties are all leased to licensed and regulated cannabis tenants and are located in areas with established zoning and permitting procedures.

The firm recently released its latest financial results, which show increases in its revenues. It remains committed to expanding its acquisition pipeline and delivering commercial real estate solutions to stakeholders in the regulated cannabis market, which will generate value for its shareholders.

Zoned Properties (ZDPY), closed Wednesday's trading session at $0.71, even for the day, on 22 volume. The average volume for the last 3 months is 242,303 and the stock's 52-week low/high is $0.53/$0.845.

BIT Mining Ltd. (BTCM)

QualityStocks, MarketClub Analysis, Schaeffer's, StockEarnings, Wall St. Warrior, The Stock Dork, StocksEarning, smartmoneytrading, MarketBeat, INO Market Report, CryptoCurrencyWire and 247 Market News reported earlier on BIT Mining Ltd. (BTCM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A recent survey found that more than one-third of TikTok crypto influencers, the most popular social media platform among the younger demographic, have shared false information about buying Bitcoin and other cryptocurrencies. The majority of TikTok’s active users are young individuals, some of whom are beginning to think about money management. An estimated 70% of users, according to estimates from earlier this year, were below 34 years of age, making them easy prey for tricks and scams because they lacked expertise.

According to the DappGambl study, a lot of influencers spread unreliable information regarding cryptocurrency investments, frequently attempting to lure naïve viewers into spending their own or their parents’ money on unprofitable crypto assets.

The focus of cryptocurrency advertising has remained the domain of Web3 influencers and tech entrepreneurs online, despite the decline in high-profile advertisements for digital assets.

Many of the influencers utilize the hashtag “#cryptok” while uploading cryptocurrency-related content. DappGambl examined 1,161 TikTok videos and discovered that two out of every three were deceptive. The study also discovered that only two out of every 20 “cryptok” videos or accounts had some kind of disclaimer warning viewers about the hazards of investing in crypto.

Almost 50% of the cryptocurrency TikTok influencers are attempting to monetize by promoting these services. In the meantime, famous influencers such as Soulja Boy, Jake Paul and Kim Kardashian have also been charged for marketing cryptocurrency to their followers without revealing the fees they received. Kim Kardashian was fined $1.26 million by the U.S. Securities and Exchange Commission for endorsing EthereumMax (EMAX).

Despite having a smaller audience than their mainstream equivalents, crypto influencers nevertheless pose a significant financial danger to naive investors.

Additionally, the study discovered that two in six false videos on TikTok reference Bitcoin. Additionally, more than 6 billion views have been accumulated for TikTok videos with common crypto-related hashtags, including #cryptok, #crypto, #cryptoadvice, #cryptoinvesting, #cryptocurrency, and #cryptotrading.

Viewers frequently ignore the bad intentions of influencers and believe their content just because it has received a significant number of likes and views. It is advisable for both new and seasoned investors to thoroughly investigate cryptocurrency initiatives before making any kind of investment.

This survey comes amid efforts to compel the Chinese-owned company to sell off its US-based operations. Shou Chew, the CEO of TikTok, testified before the U.S. Congress last month during a five-hour session that made clear how skeptical lawmakers were of the social media platform.

Crypto industry actors such as BIT Mining Ltd. (NYSE: BTCM) have much work to do to counter the misleading information proliferating on various social media platforms so that the nascent industry isn’t stained by these unscrupulous actors.

BIT Mining Ltd. (BTCM), closed Wednesday's trading session at $2.85, up 11.7647%, on 248,150 volume. The average volume for the last 3 months is 1.21M and the stock's 52-week low/high is $1.40/$23.80.

Cenntro Electric Group Ltd. (CENN)

QualityStocks, TradersPro, GreenCarStocks, Penny Stock and InvestorPlace reported earlier on Cenntro Electric Group Ltd. (CENN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

U.S. President Joe Biden has pledged that by 2032, two-thirds of all new vehicles sold in the country will be powered by electricity. Many significant manufacturers, such as General Motors, have declared that they will completely discontinue producing ICE vehicles in 2035. The future generation of auto mechanics will also be impacted by this change, in addition to drivers.

Many workers in this business will be driven out by the rise of electric cars, according to Sam Cicinelli. That is mainly because electric cars require less maintenance. AAA estimates that the average annual maintenance cost of conventional vehicles is $949, while that of electric cars is $330 less.

An electric vehicle has fewer components that need to be fixed. An electric vehicle has only 13,000 movable components, compared to 33,000 in traditional vehicles. Electric vehicles do not require changing oil or oil filters. Additionally, EVs do not have cooling mechanisms to prevent overheating because they do not have engines. Electric vehicle brakes still require replacement, although less frequently than in conventional vehicles.

However, change is on the way. According to the Bureau of Labor Statistics, there won’t be enough new job vacancies in this particular industry, and the majority of the jobs are going to be replacements for individuals who are departing the profession. It warns that the “growing popularity of electric cars could curtail demand for technicians in the future.”

The effects of electric vehicles on these jobs are starting to show up in California, which has the highest number of auto mechanics and has 39% of all electric vehicles in America. The state’s total number of authorized independent car shops has decreased by more than 13% since 2014.

According to Dave Kusa, businesses are closing down due to a combination of their lengthy warranties and the fact that electric vehicles present fewer options for servicing. The Ford F-150, the top selling car in America, has a three-year or 36,000-mile warranty. Thanks to government regulations, electric vehicles are covered by a warranty of eight years or 100,000 miles, particularly for the battery, which covers replacement prices of between $4,000 and $20,000. As a result, owners of electric vehicles must service their vehicles at car dealers rather than individual shops.

Most repairs on electric vehicles require more computer knowledge than mechanical know-how; therefore, mechanics would have to undergo retraining. Since they must acquire a completely new set of skills, many mechanics are hesitant to change, according to David Favre. Many older mechanics are not interested in rebuilding and adjusting their toolbox, he said.

Needless to say, electric vehicle startups such as Cenntro Electric Group Ltd. (NASDAQ: CENN) know that establishing a network of technicians who will maintain and repair their EV models is crucial to cementing their place on the market.

Cenntro Electric Group Ltd. (CENN), closed Wednesday's trading session at $0.3554, up 0.879932%, on 1,219,221 volume. The average volume for the last 3 months is 7.21M and the stock's 52-week low/high is $0.26/$2.27.

Newmont Corporation (NEM)

MarketClub Analysis, InvestorPlace, The Street, Kiplinger Today, Schaeffer's, StocksEarning, MarketBeat, INO.com Market Report, The Online Investor, Barchart, Investopedia, StreetAuthority Daily, Daily Trade Alert, TopStockAnalysts, Top Pros' Top Picks, StreetInsider, Louis Navellier, Streetwise Reports, Daily Wealth, SmarTrend Newsletters, Zacks, Money Morning, Uncommon Wisdom, TradingMarkets, Marketbeat.com, PROFIT CONFIDENTIAL, Wealth Daily, Trades Of The Day, The Growth Stock Wire, TheStockAdvisor, QualityStocks, The Wealth Report, Lebed.biz, ProfitableTrading, Wall Street Grand, Cabot Wealth, Investing Signal, TheStockAdvisors, Dividend Opportunities, The Best Newsletters, Market Intelligence Center Alert, All about trends, National Inflation Association, Trading Markets, Energy and Capital, Market FN, Trading Tips, Wyatt Investment Research, InvestmentHouse, Stockhouse, Money and Markets, Darwin Investing Network, AllPennyStocks, Investment House, Wall Street Daily, Street Insider, OTC Stock Pick, Daily Markets, TradingAuthority Daily, InvestorsObserver Team, Buttonwood Research, Wall Street Greek, InvestorIntel, Investors Alley, StockEarnings, The Tycoon Report, StreetAlerts, Investiv, DividendStocks, Dynamic Wealth Report, Eagle Financial Publications, Wealth Insider Alert, Investment U, Trader Jack, Investing Futures, 24/7 Trader, Trading Concepts, The Stock Enthusiast, StockTwits, Daily Profit, Early Bird, FutureMoneyTrends.com, Market Authority, FNNO Newsletters, Short Term Wealth, MarketWatch, Global Equity Alert, Global Equity Report, Investing Daily, equities Canada, INO Market Report, CrushTheStreet.com, CNBC Breaking News, Candle Stick Forum, ChartAdvisor, Insider Wealth Alert, Total Wealth, Normandy Investment Research, SmallCap Network, Super Stock Picker, The Motley Fool, The Street Report, Seeking Alpha, The Weekly Options Trader, Profits Run, Trade of the Week, UndiscoveredEquities, Vantage Wire, VectorVest, Wall Street Window, Weekly Wizards, The Wall Street Transcript, One Hot Stock, Investor Update, Investors Insights, Jim Cramer, Leeb's Market Forecast, MarketClub, Small Cap Firm, Navellier Growth, Investor Guide, OTCPicks, Penny Detectives, Penny Stock Buzz, PennyStockProphet, Power Profit Trades, Profitable Trader Authority and MiningNewsWire reported earlier on Newmont Corporation (NEM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Switzerland is the biggest exporter of gold globally, followed closely by the United Arab Emirates, the United Kingdom and the United States. Switzerland imports refined and branded gold from other countries before exporting it to other nations where jewelry and other accessories are made.

The precious metal’s trade model is, however, easily infiltrated by money launderers and smugglers who use it to sell gold from suspicious sources and launder funds. This was clearly seen in the recent investigation done by Al Jazeera’s I-Unit dubbed the Gold Mafia, which aired in four parts.

The investigative unit had undercover journalists pretend to be Chinese criminals interested in laundering more than $100 million of dirty funds using gold from Zimbabwe. While gold is the biggest export of Zimbabwe, the country can’t sell the precious metal globally because of Western sanctions imposed over violations of human rights.

Ewan Macmillan and Kamlesh Pattni were two smuggling kingpins approached by the reporters who admitted to ferrying gold abroad. Both revealed that they sent their couriers with gold to Dubai, with Macmillan’s business partner Alistair Mathias advising the “criminals” to establish front companies in the U.A.E.

They explained the smuggling process, noting that once the gold reached Dubai, it was melted and rebranded as Dubai Gold. This current model makes it particularly hard for law enforcement agencies to gather evidence against smugglers. Amjad Rihan, a partner at Ernst Young, notes that the origins of refined gold are virtually untraceable, which is perfect for smugglers.

Experts also found that the process of hiding the precious metal’s origins means that Dubai gold would sometimes be exported to Switzerland or England. Mark Pieth, an anticorruption and money laundering expert, explained that gold with the Swiss Gold stamp could be easily bought by banks globally.

Currently, the United Arab Emirates exports about 23% of its gold to Switzerland.

The Aljazeera investigation also showed how South African money launderer Mohamed Khan moved millions of dollars as payments for absent imports using shell companies and fake invoices. One of the companies used, Velmont Valley, received almost $16 million in a Swiss bank account from Gold Leaf Tobacco in May 2017. Gold Leaf Tobacco is a cigarette manufacturing firm owned by Simon Rudland, a Zimbabwean millionaire. Rudland has, in the past, been accused of evading taxes by selling cigarettes on the illicit market.

Gangs involved in gold smuggling in Switzerland also use Switzerland as a safe haven.

This situation likely poses a threat to legitimate players in the gold industry such as Newmont Corporation (NYSE: NEM) (TSX: NGT) and a concrete plan needs to be designed to weed out bad actors from this industry.

Newmont Corporation (NEM), closed Wednesday's trading session at $47.15, off by 2.1784%, on 7,558,372 volume. The average volume for the last 3 months is 21,125 and the stock's 52-week low/high is $37.45/$74.985.

The QualityStocks Company Corner

Silo Pharma Inc. (OTCQB: SILO)

The QualityStocks Daily Newsletter would like to spotlight Silo Pharma Inc. (OTCQB: SILO).

Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K7A) ("Silo" or "the Company")is pleased to announce that on April 25, 2023 it has signed abinding letter of intent to acquire the BitGift asset from MoonEquity Holdings (OTC Pink: MONI) ("MONI") for up to CAD$500,000.The BitGift platform, designed for secure and anonymouscryptocurrency transactions, presents an opportunity to address thechallenges faced by licensed psilocybin operators in Oregon inadhering to banking and anti-money laundering regulations. Toensure compliance with these laws, Silo Wellness and BitGift wouldattempt to collaborate with other providers and industry experts todevelop and implement robust Know Your Customer (KYC) andAnti-Money Laundering (AML) procedures, including but not limitedto identity verification, transaction monitoring, risk assessment,and regulatory reporting. "We are looking at BitGift as a potential'picks and shovels' service to help quickly steer away Oregonpsilocybin from a dangerous cash-only system," said Mike Arnold,CEO of Silo Wellness. "We are excited to explore this opportunityfurther and work with MONI to complete our due diligence andquickly finalize the transaction.

Silo Pharma Inc. (OTCQB: SILO), a developmental stage biopharmaceutical company, is focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as post-traumatic stress disorder (PTSD), fibromyalgia, Alzheimer’s disease, Parkinson’s disease, and other rare neurological disorders. Silo’s mission is to identify assets to license and fund research that the company believes will be transformative to the wellbeing of patients and the health care industry.

Silo is committed to developing innovative solutions to address a variety of underserved conditions. Combining Silo’s resources with world-class medical research partners, the company looks to make significant advances in the medical and psychedelic space.

Silo works to identify and partner with leading medical universities, providing the needed financial resources to develop safe therapeutic treatments while moving cutting-edge research through the clinical stage and into commercialization. The company is well-capitalized with access to additional funds as opportunities present themselves.

Silo recently engaged Donohoe Advisory Associates LLC for consulting and advisory services in connection with the potential uplisting of Silo’s common shares to the Nasdaq Stock Market.

Research

Silo has entered into research agreements and partnerships with multiple leading medical universities.

The company is involved in a sponsored study with Maastricht University utilizing repeated low doses of ketamine and psilocybin to examine the effects on cognitive and emotional dysfunctions in Parkinson’s disease and to understand its mechanism of action. The investigator in the Netherlands is acquiring the substances for the study and will then finalize the documentation to submit to the ethics committee.

Additionally, in June 2021, Silo announced its entry into a scientific research agreement with the University of California San Francisco (UCSF). The agreement will leverage four other clinical trials being planned by the university to determine the effects of psilocybin on inflammation. The study will take place at The Translational Psychedelic Research (TrPR) Program at UCSF.

Silo also recently extended its exclusive option agreement with the University of Maryland, Baltimore (UMB) to explore a novel invention generally known as joint-homing peptides. These peptides are being developed for use in the investigation and treatment of arthritogenic processes and can be used for enhanced targeting of therapeutic agents.

This agreement includes the study of two separate peptides. The first is an option and study for the treatment of arthritis. The second is a patented licensed peptide for the central nervous system, with an initial study for MS autoimmune diseases, in addition to rheumatoid arthritis. Animal studies are underway for both initial indications relating to the UMB agreement, with the potential for studies evaluating additional indications in the future.

Finally, Silo signed an agreement with Columbia University granting it an option to license certain assets currently under development, including an Alzheimer’s disease formulation targeting NDMARs and 5-HT4Rs, as well as a prophylactic treatment for stress-induced disorders and PTSD. Both candidates are currently being tested in mice and have already provided early data.

In addition to its university partnerships, Silo entered a joint venture agreement with Zylo Therapeutics Inc. (“ZTI”) focused on the development of ketamine and psilocybin using ZTI’s Z-Pod™ technology for the transdermal time released delivery of therapeutics. In November 2021, the company announced ZTI’s reception of its first ketamine shipment and initiation of loading ketamine into its Z-Pod technology. In a news release, Eric Weisblum, CEO of Silo, called the development an “important milestone” that will help the company “study the benefits of slow-release transdermal release of Ketamine.”

Market Overview

According to Coherent Market Insights, the fibromyalgia treatment market was valued at $2.78 billion in 2018 and has a projected CAGR of 3.3% over the forecast period 2018 to 2026. Fibromyalgia is a condition that causes pain all over the body, sleep problems, fatigue, and emotional and mental distress.

The global PTSD therapeutics market is expected to reach $10.68 billion by 2026 with a CAGR of 4.5% during the forecast period from 2018 to 2026, according to a report by Credence Research. Growing prevalence of PTSD is the chief factor driving the global treatment market. Increases in events such as wars, combat, and interpersonal violence has been a major contributing factor. Other factors like growing emphasis on rehabilitation initiatives by governments for treating their war veterans has also been facilitating the increase in demand for PTSD therapeutics.

Fortune Business Insights reports the global Parkinson’s disease treatment market is predicted to grow to $8.38 billion by 2026, with a CAGR of 8.1% during the forecast period. Parkinson’s is a neurodegenerative disease of the central nervous system which primarily affects the brain, causing uncontrollable shaking and tremors, difficulties in balance and restricted body movement making it difficult for the person to function or perform a daily routine.

Management Team

Eric Weisblum is CEO and founder of Silo Pharma. He has over 25 years of Wall Street experience, most recently in the biotechnology sector. He has served on the board of Aikido Pharma and was the president of Sableridge Capital. He has a proven track record in licensing therapeutic assets and assisting in their development. He brings to the company nearly 20 years of expertise in structuring and trading financial instruments. He holds a bachelor’s degree from the University of Hartford’s Barney School of Business.

Dr. Kevin Muñoz was appointed to the Silo board of directors in October 2020. He teaches biomedical sciences and medical intervention for the Passaic County Technical Institute. He previously served as Director of Operations at Physical Medicine and Rehabilitation. He began his career with Harlem Health Promotion Center in New York City as a research assistant. He earned a bachelor’s degree from the University of Michigan and a Doctor of Medicine from Xavier University School of Medicine.

Josh Woolley, M.D., Ph.D., is a Scientific Advisor for Silo. He is an associate professor in the Department of Psychiatry and Behavioral Sciences at the University of California, San Francisco. He is also a psychiatrist on staff at the San Francisco Veterans Affairs Medical Center. He is the director and founder of the Bonding and Attunement in Neuropsychiatric Disorders Laboratory. He received both his M.D. and his Ph.D. in Neuroscience from UCSF, where he completed his psychiatry residency training.

Charles Nemeroff, M.D., Ph.D., is a Scientific Advisor for Silo Pharma. He directs the Institute for Early Life Adversity Research within the Department of Psychiatry and Behavioral Sciences as part of the Mulva Clinic for the Neurosciences. He was chair of the Department of Psychiatry and Behavioral Sciences and clinical director of the Center on Aging at the University of Miami Miller School of Medicine. He received his M.D. and Ph.D. in neurobiology from the University of North Carolina School of Medicine.

Silo Pharma Inc. (OTCQB: SILO), closed Wednesday's trading session at $2.27, up 8.0952%, on 23,367 volume. The average volume for the last 3 months is 68,103 and the stock's 52-week low/high is $1.71/$12.225.

Recent News

IGC Pharma Inc. (NYSE American: IGC)

The QualityStocks Daily Newsletter would like to spotlight IGC Pharma Inc. (NYSE American: IGC).

New York Governor Kathy Hochul has announced that the state is initiating a campaign to urge persons 21 years and older to purchase cannabis fromlicensed dispensaries. The move is meant to make sure that peoplebuy safe products and that profits are directed toward achievingequity and reinvestment objectives. Hochul stated the “Why BuyLegal New York” initiative will debut around April 20, 2023, theunofficial cannabis holiday, to capitalize on the heightenedawareness surrounding cannabis-related issues. The campaign is premised on reaching consumers aged 21 or older via educationalmaterials; digital advertisements, such as a handbook on safeconsumption habits; visuals as well as movies that feature licensedmarijuana business owners; and messaging about the benefits ofparticipating in the legal market. As the recreational market getsunderway in New York State, there are also some enterprises suchas IGC Pharma Inc. (NYSE American: IGC) that are hard at work developing therapeutic formulations fromselect constituents of this plant.

IGC Pharma Inc. (NYSE American: IGC), through subsidiary IGC Pharma, develops, patents, and markets advanced THC-based drug formulations for the treatment of symptoms related to various diseases including but not limited to Alzheimer’s disease, Tourette syndrome, chronic pain, and pet seizures.

IGC’s leading drug candidate, IGC-AD1, has completed Phase 1 of a safety and tolerability trial and entered Phase 2 trials for treating agitation in patients with Alzheimer’s dementia, the first study in humans of a natural tetrahydrocannabinol (THC) compound plus another molecule (www.clinicaltrials.gov). As of September 2022, the IGC trial is the only ongoing Phase 2 trial of a natural THC-based formulation on Alzheimer’s patients.

The company’s other drug candidate, TGR-63, is an enzyme inhibitor that has shown in preclinical trials the potential to reduce neurotoxicity in Alzheimer’s cell lines. Both drug candidates have shown their ability to ameliorate beta amyloid plaques in Alzheimer’s cell lines and improve memory in Alzheimer’s mouse models. Beta amyloid plaques are a key hallmark of Alzheimer’s and an important target of Alzheimer’s pharmaceutical drug development.

Neuro Psychiatric Symptoms (NPS) are not only debilitating for Alzheimer’s patients; they also place an immense emotional burden on their caregivers. Beyond reducing symptoms, IGC-AD1’s active molecules and TGR-63 have also shown promise in preclinical trials to reduce important hallmarks of Alzheimer’s including plaques and tangles, as well as improving the treatment of memory loss.

Over the past eight years, the IGC team has amassed a deep knowledge of cannabinoid science, including extraction, isolation, purification, and development. The company’s strategy is to leverage its unique end-to-end capabilities, platform, and expertise to develop a class-leading program and bring it to market quickly and cost efficiently to treat neurodegenerative diseases such as Alzheimer’s.

The company also has a family of cannabidiol (CBD)-based consumer products (www.Holief.com) such as pain relief creams, pain relief gels, purpose gummies, tinctures, and capsules targeting women’s wellness, with a particular focus on premenstrual syndrome (PMS) and dysmenorrhea (period cramps). In addition, the company targets individuals that need sleep-aids with its specially formulated low melatonin cannabinoid gummies.

IGC has also introduced a low-calorie CBD- and caffeine-infused energy beverage brand (www.SundaySeltzer.com) that is currently available for purchase. The company’s brands are founded on the belief that effective natural solutions should be affordable and accessible to everyone. As the demand for natural products targeting women’s wellness and energy drinks continue to grow, these products are seeing strong traction in the market.

The company operates three facilities – a large GMP (Good Manufacturing Production Standards) certified facility that includes extraction, distillation, and manufacturing, in Washington State; a GMP-211 (pharmaceutical) grade facility in Maryland; and a facility licensed for controlled substances including cannabis in Bogota, Colombia, with complete access to legal licensed cannabis where the company conducts its testing.

In addition, the company’s development under Magistral Formulations is approved by INVIMA (Colombia National Food and Drug Surveillance Institute) to treat neurological disorders, non-oncological chronic pain, and mental disorders.

IGC’s intellectual property (IP) portfolio comprises of eight patents that it controls and seven patent applications. The portfolio includes #11,446,276, a patent for extreme low dose THC treatment of Alzheimer’s that was granted in September 2022.

The company is headquartered in Potomac, Maryland.

IGC-AD1

IGC-AD1 is the company’s leading drug candidate for the treatment and relief of Alzheimer’s symptoms. A significant amount of research on Alzheimer’s cell lines has shown that the active agents in IGC-AD1 reduce plaques and neurofibrillary tangles that are the hallmarks of Alzheimer’s. Further, micro-dosing of THC, as shown in cell lines, could increase the functioning of mitochondria and potentially promote the growth of new neural pathways (neurogenesis). The research shows that micro-dosing of THC affects the brain radically differently from the normal higher dosing of THC.

While there is a significant body of research showing that THC is neuro-toxic at normal levels of dosing, micro-dosing of THC has been shown to be non-toxic to neurons. With the results of these preclinical studies, the company developed an oral formulation, IGC-AD1. The company recently completed a safety and tolerability Phase 1 trial on Alzheimer’s patients and has initiated a Phase 2, multi-site, double-blind, randomized, placebo-controlled trial of the safety and efficacy of IGC-AD1 on agitation in participants with dementia due to Alzheimer’s disease at sites in the U.S. and Canada. IGC expects the Phase 2 trial to take between 9 and 12 months to complete, barring unknown factors such as, for example, a resurgence of COVID and the enforcement of lockdowns and travel restrictions.

With further successful trials and FDA approvals, IGC hopes to bring a drug based on natural THC as an effective treatment for agitation in Alzheimer’s to market.

TGR-63

The company’s other molecule, TGR-63, has been shown to reduce the neurotoxicity that impacts memory loss in preclinical trials with mice. On a dose dependent manner, transgenic Alzheimer’s mice treated with TGR-63 showed improvement in memory relative to control.

Both drug candidates, IGC-AD1 and TGR-63, have shown their ability to reduce the brain plaques associated with memory loss in Alzheimer’s in mice.

With further successful trials and FDA approvals, IGC hopes to bring TGR-63 as a treatment for Alzheimer’s disease to market.

Market Opportunity

Alzheimer’s disease impacts over 55 million people worldwide and about 5.5 million individuals in the U.S. Over 70% of these patients face debilitating symptoms, including anxiety, depression, and agitation (Mendez, 2021). Agitation in dementia patients can include excessive physical movement and verbal activity, restlessness, pacing, belligerence, aggression, screaming, crying, and wandering.

In 2020, the estimated healthcare costs for Alzheimer’s disease in the U.S. were $305 billion. Medicare and Medicaid covered about 70% of those costs, leaving considerable burden on patients and families. At the current rate of growth of Alzheimer’s and other dementia diagnoses, those costs are estimated to reach over $1 trillion by 2050.

Currently, there are no FDA-approved medications to alleviate the symptoms of dementia due to Alzheimer’s disease, providing a tremendous opportunity for formulations that can have an impact on quality of life and disease progression.

Management Team

Richard Prins has been chairman at IGC since 2012 and served as an independent director since 2007. From March 1996 to 2008, he was the Director of Investment Banking at Ferris, Baker Watts, Incorporated. Prins served in a consulting role to RBC until January 2009. He currently volunteers full time with a non-profit organization, Advancing Native Missions, and is a private investor. Since February 2003, he has been on the board of Amphastar Pharmaceuticals Inc. He holds a bachelor’s degree from Colgate University and an MBA from Oral Roberts University.

Ram Mukunda is CEO and President of IGC. He has been the chief inventor and architect of most of the company’s patent filings and is responsible for the company’s strategic positioning. Prior to IGC, he was founder and CEO of Startec Global Communications, which he took public in 1997. He served as Strategic Planning Advisor at Intelsat, a communications satellite services provider. From 2001 to 2003, he was a Council Member at Harvard’s Kennedy School of Government, Belfer Center of Science and International Affairs. He was named the 1998 Ernst & Young Entrepreneur of the Year. He holds bachelor’s degrees in electrical engineering and mathematics, and a master’s degree in engineering from the University of Maryland.

Dr. Jagadeesh Rao is the company’s Principal Scientist. His career spans two decades in the public sector and product R&D for Johnson & Johnson. He leads IGC’s scientists in the development of pharmaceutical and OTC products. He worked for the federal National Institutes of Health, and for the National Institute on Drug Abuse. His Ph.D. in Neurochemistry is from the National Institute of Mental Health & Neurosciences in India. He did postdoctoral training at the University of Illinois-Chicago.

Claudia Grimaldi is a Director, Vice President, Principal Financial Officer, and Chief Compliance Officer for IGC. She also serves as a Director/Manager Director for some of the company’s subsidiaries. She graduated with highest honors from Javeriana University in Colombia with a bachelor’s degree in psychology. She holds an MBA, graduating with highest honors, from Meredith College in North Carolina. In addition, she has attended the Darden School of Business Financial Management Executives program and the Corporate Governance Program at Columbia Business School. She is currently pursuing her Directorship Certification with the National Association of Corporate Directors. She is fluent in both English and Spanish.

IGC Pharma Inc. (NYSE American: IGC), closed Wednesday's trading session at $0.338, up 1.8692%, on 92,796 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $12.225/$.

Recent News

Data443 Risk Mitigation Inc. (OTC: ATDS)

The QualityStocks Daily Newsletter would like to spotlight Data443 Risk Mitigation Inc. (OTC: ATDS).

Data443 Risk Mitigation (OTC: ATDS), a data security and privacy software company for “All Things DataSecurity,” has released an update to its award-winning RansomwareRecovery Manager (“RRM”) product. According to the company, thisversion includes new advanced features that enable businesses andindividuals to recover from ransomware attacks quickly and easily.New features include the following: enhanced compatibility with themost recent hacking and ransomware threats; optimized data restoreactivities; advanced threat-detection capabilities; faster reactiontime; and full support for Microsoft Windows 11 and MicrosoftServer 2019 and 2022; native support for the Eset antivirus is alsoincluded. Experts report that ransomware attacks are becoming morefrequent and sophisticated, leaving businesses and individuals atrisk of lost data and finances, along with reputational damage. “Weare thrilled to announce the latest update to our ransomwarerecovery software solution,” said Data443 Risk Mitigation founderand CEO Jason Remillard in the press release. “We understand thedevastating impact that ransomware attacks can have, and we arecommitted to providing the most supported platform portfolio of anyfull data and ransomware recovery platform on the market. Majortesting and certification activities give our customers peace ofmind and even greater protection. The product roadmap is veryexciting – including Microsoft Windows Defender support, newinterfaces for administrators to control the product remotely and acloud-based console.”

To view the full press release, visit https://ibn.fm/KigVN

Data443 Risk Mitigation Inc. (OTC: ATDS) is a data security and privacy software company for ALL THINGS DATA SECURITY™. The company is committed to organizing the world’s information by identifying and protecting all sensitive data regardless of location, platform or format.

Data443 provides software and services to enable secure data across devices and databases – at rest and in transit – locally, on a network, or in the cloud. With over 10,000 customers in more than 100 countries, Data443 provides a modern approach to data governance and security. The company’s framework helps customers prioritize risk, identify security gaps, and implement effective data protection and privacy management strategies.

Data443 derives revenue primarily from contracts for subscriptions to access its SaaS platforms, and ancillary services provided in connection with its subscription services. In today’s ever-changing environment with unique and complex requirements for data privacy, governance and hybrid workforces, every organization needs to know where all their data is, who has access to it and how sensitive it is. Data443 provides the tools needed to give companies control over their data processing activities, with capabilities for identifying, reporting and migrating or deleting sensitive data.

The company is headquartered in Research Triangle Park, North Carolina.

Products

Focused on data security with a privacy-forward methodology, the Data443 product suite delivers solutions designed to securely manage data and data privacy needs on-premises, in the cloud and in hybrid environments. Offerings include:

  • Data Identification Manager reduces risk by shining a light on dark data across cloud, on-premises and hybrid environments. From a centralized dashboard, Data Identification Manager provides the ability to automatically inventory all data repositories, classify and tag all data, and enable global search and discovery – all through an agentless deployment.
  • Data Placement Manager quickly and securely transfers sensitive data over any public or private network. Available as an HP Nonstop server-based application and for Windows, Linux or any public cloud provider, Data Placement Manager enables the scheduling, routing, formatting and transfer of business-critical data.
  • Data Archive Manager is an “all information, anywhere” archiving solution designed to handle and manage all types of privacy requests across cloud, on-premises and hybrid environments. With over 15 years operational history and hundreds of clients managing millions of mailboxes, the platform is purpose-built for information archiving, retention and privacy request management.
  • Data Hound™ is a data discovery, classification and capture toolset that enables organizations to perform quick scans, detailed reporting and subsequent data actions based on policy.
  • Ransomware Recovery Manager is the only industry solution that actively recovers the device, operating system and data with a simple reboot. Using patented, proven technology, the product produces 100% effectiveness for the whole device and datasets.
  • Access Control Manager provides user ID and passwordless access to quickly enable trust across an organization’s entire ecosystem. Its unique architecture allows it to leverage multiple distributed authoritative sources to understand and resolve a typical access request – with the ability to enable or deny the action on the fly.
  • Global Privacy Manager provides organizations one comprehensive view, for all privacy requirements, across all enterprise data, all at once. This unmatched visibility into an organization’s data assets ensures that all private and sensitive data can be identified and protected and that enterprises can obey all relevant privacy laws in any jurisdiction.
  • Sensitive Content Manager is a security-centric collaboration service designed to give organizations the tools needed for successful content sharing, collaboration and safe distribution with full enterprise management in mind. With a continuous sync feature, encrypted data is automatically downloaded and updated in real time – regardless of location – ensuring that users have the most accurate data available.

Market Outlook

A report from Allied Market Research estimates that the global data security market was worth about $19 billion in 2021 and is projected to reach a value of $54.23 billion by 2027. That represents a CAGR of more than 18% for the forecast period, making data security one of the hottest areas within IT.

Separately, Fortune Business Insights estimates the global data privacy software market is valued at $2.36 billion in 2022 and projects it will grow to $25.85 billion by 2029. That represents a CAGR of 40.8% over the forecast period.

Management Team

Jason Remillard is President, CEO and Founder of Data443. He is responsible for overseeing global expansion, management, execution and corporate development. With over 25 years in global enterprise and B2C software sales and marketing, he brings deep leadership and technical experience, having spent previous time at Fortune 500 companies such as Deutsche Bank, TD Bank, IBM & Merrill Lynch.

Greg McCraw is CFO at Data443. He has over 25 years of experience helping businesses strengthen their accounting and finance operations. He previously served as Vice President of Finance for a dental services organization active in acquisitions, and, prior to that, he was managing director of a boutique accounting and finance consulting firm advising Fortune 500 clients in pharmaceutical, financial services, and private equity sectors on how to execute on regulatory and compliance solutions.

Bennett Pursell is Data443’s Chief Technology Officer. He has over 20 years of experience in IT architecture, security governance and systems integration. Prior to his role at Data443, he served as Head of Technology Architecture at Moody’s Investor Services and was Vice President and Technical Architect of Cloud Computing at Deutsche Bank, along with a host of technical and project management roles dating back to 2006, after starting his career as a web developer with a few startups and running research labs.

Kirill Kashigin is Chief Software Architect at Data443. He leads the development and quality teams, and serves as technical adviser and subject matter expert, bringing vast technical knowledge on privacy management and data security. Formerly the CTO of FileFacets, he has nearly 20 years in development of high-performance systems and deployment.

Data443 Risk Mitigation Inc. (OTC: ATDS), closed Wednesday's trading session at $0.047, up 4.4444%, on 13,231 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.025/$6.99.

Recent News

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF)

The QualityStocks Daily Newsletter would like to spotlight Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF).

Lithium-ion batteries power modern technologies, but anothercritical element is required to build them – graphite, thebattery’s single largest component, the production of which ismainly controlled by China

Currently, no significant production of lithium-ion battery anodematerial exists in North America; resuming domestic graphiteproduction emerges as critical in reducing reliance on foreignsupply and increasing energy self-sufficiency amid growinginternational geopolitical tensions

Reflex Advanced Materials seeks to fill the market gap byreactivating domestic mining operations of flake and vein graphite;with direct access to top-notch supply chain partners, it isuniquely positioned in the market as a provider of domesticgraphite

Essential to modern technologies, critical minerals are ofstrategic importance to countries around the world, especiallythose that rush to expedite energy transition and decarbonize theeconomy. This is where companies like Reflex Advanced Materials (CSE: RFLX) (OTCQB: RFLXF), a company focused on strategic metals and advanced materialsspace, aim to step in to deliver minerals needed to power moderndevices.

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) is a strategic minerals company focused on locating and developing economic properties in the strategic metals and advanced materials space. The company aims to improve domestic specialty mineral infrastructure efficiencies to meet surging national demand from North American manufacturers, effectively positioning itself as one of the only North American suppliers of high purity natural graphite for hi-tech applications.

Reflex Advanced Materials is based in Vancouver, British Columbia. Its project portfolio includes the Ruby Graphite Deposit in Montana and the ZigZag Lithium Property in Ontario.

Projects

Ruby Graphite Project

Located in a mining-friendly jurisdiction in southwest Montana, the Ruby Graphite Deposit is a low cost, rapid re-entry opportunity that produced roughly 2,400 tons of graphite from 1902 to 1948. Reflex Advanced Materials holds mining rights for 755 hectares at the Ruby Graphite Project, with 96 federal lode mining claims. Recent samples assay at 95.8% to 98.4% total carbon.

The site is notable as the only combined U.S. graphite flake and vein graphite source. Vein graphite is ideal for energy storage applications, because it requires fewer steps to achieve purity than synthetic alternatives and is therefore far less environmentally damaging. This is expected to play a key role in the project’s development as demand for electric vehicles continues to surge.

In March 2023, the company announced its submittal of permit applications to the Bureau of Land Management in respect of its exploration of the Ruby Graphite Project. Its initial drill program, expected to take place in the summer of 2023, includes plans for 3,500 total meters of drilling, cored to an average depth of 130 meters. The targets for this drill program have been identified using historical data from original mine operations and data gathered for the initial 43-101 technical report on the project, dated January 31, 2023.

ZigZag Lithium Property

Located in the Thunder Bay Mining Division of Ontario, the ZigZag Lithium Property consists of eight mining claims spanning roughly 2,710 hectares. Mineralization at the property, most notably lithium, is based in pegmatite dikes and concentrated in spodumene crystals, which are consistent throughout the entire unit.

Spodumene is readily observable in outcrops and in drill cores, with crystal sizes ranging from 3-15cm, on average.

Reflex Advanced Materials and American Energy Technologies Company Metallurgical Partnership

Reflex Advanced Materials has entered into a material processing agreement with American Energy Technologies Co., which is based in Arlington Heights, Illinois, to conduct metallurgical testwork with the goal of creating a technical support data package for Reflex’s target customer base, U.S. Federal agencies and qualification programs with hi-tech customers in the battery and battery storage business.

The resulting coated, spherionized, purified graphite (CSPG) material that is expected to be created from the aforementioned tests will be used to provide potential customers of CSPG with samples so that they can begin the material qualification process.

Market Opportunity

Graphite is an ideal battery anode and has dominated the market since the proliferation of lithium-ion batteries. Despite this demand, there is currently no significant production of lithium-ion battery anode material in North America.

Instead, most graphite sold in North America today is sourced from Chinese producers. U.S. President Joe Biden highlighted this sourcing disparity in a 2022 address:

“The United Stated depends on unreliable foreign sources for many of the strategic and critical materials necessary for the clean energy transition – such as lithium, nickel, cobalt, graphite and manganese for large-capacity batteries,” he said. “Demand for such materials is projected to increase exponentially as the world transitions to a clean energy economy.”

The U.S. Department of Energy is in the process of awarding $2.8 billion to expand domestic manufacturing of batteries for electric vehicles and combat this foreign dependency. Reflex Advanced Materials has identified its Ruby Graphite Project as a prime candidate for U.S.-sponsored initiatives due to the rarity and scarcity of natural graphite deposits in the country.

Processing graphite domestically in the U.S. is expected to provide Reflex Advanced Materials a competitive advantage as manufacturers begin to seek out American supply in the face of increased diplomatic tension. This is critical, as a rise in anode demand is expected to fuel a shortage of 8 million tonnes of graphite by 2040. World Bank Group projects 494% growth in total graphite demand by 2050.

Leadership Team

Paul Gorman is the CEO and a Director of Reflex Advanced Materials. He brings to the company over 25 years of experience in junior mining finance, public listings, viability assessment and operational rationalization. For 18 years, Mr. Gorman served as president and managing partner of Riverbank Capital, where he played an instrumental role in raising more than $85 million for small-cap companies. In 2008, he funded Industrial Minerals Inc. (later Northern Graphite) and served in an advisory role for four other graphite companies, contributing significantly to the revitalization of the junior graphite space in North America. Mr. Gorman founded Mega Graphite Inc. in 2009 and has served as chief executive for three other companies.

Tasheel Jeerh, CPA, is the company’s CFO. He is a finance and accounting professional with over a decade of experience spanning both public and private sectors. Prior to joining Reflex Advanced Materials, Mr. Jeerh played a pivotal role in the growth of a private upstream oil and gas firm, dealing with over $2 billion in M&A activity and $1 billion in financing activities. He gained his designation at PricewaterhouseCoopers, where he worked as a manager in the assurance practice.

Greg Bell is Project Manager for Reflex Advanced Materials. He is a multi-disciplined engineering management professional with more than 40 years of experience in the natural resources sector. Mr. Bell has successfully built and managed several start-up operations in various capacities. He has been active in graphite and lithium exploration for the past seven years.

Christopher W. Hill leads the company’s Corporate Development initiatives. He is an investor and entrepreneur with over a decade of experience in the capital markets. Mr. Hill began his career as an investment advisor and then began to consult and advise private companies on their paths to becoming publicly traded. He specializes in corporate development and strategic financing utilizing his large network in the capital markets.

Reflex Advanced Materials Corp. (RFLXF), closed Wednesday's trading session at $0.48, even for the day, on 245 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.25/$0.765.

Recent News

Advanced Container Technologies Inc. (OTC: ACTX)

The QualityStocks Daily Newsletter would like to spotlight Advanced Container Technologies Inc. (OTC: ACTX).

April 20, or 4/20 as the day is normally referred to, is anunofficial holiday celebrated by marijuana smokers across theUnites States and in other parts of the world. Marijuana retailersin America marked the day with in-store events, deals andpromotions geared toward meeting their consumers’ needs and attracting new customers.Many planned to run their promotions for a week or even a monthinstead of one day, which would go a long way in bringing in foottraffic. Historically, 4/20 is a boon for marijuana retailers,with Treez CEOJohn Yang revealing that in 2022, the company’s aggregated salesincreased by 25% during this holiday period. The marijuana industryis growing from strength to strength with each passing year, andthis growth is leading to the opening up of opportunities foraffiliated companies such as Advanced Container Technologies Inc. (OTC: ACTX) that don’t directly deal in marijuana but offer ancillary servicesand products.

Advanced Container Technologies Inc. (OTC: ACTX) is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer®, that store and grind pharmaceuticals, herbs, teas and other solids or liquids.

ACTX is the leading distributor of Grow Pods. With a controlled environment, food and herbs can be grown without pesticides, harmful chemicals or risk of pathogen contamination, and with low energy consumption. Restaurants, grocery stores, non-profits, MSOs and entrepreneurs can use Grow Pods to ensure a fresh supply of ultra-clean produce year-round.

The company entered the Grow Pod business in October 2020 with its acquisition of all shares of Advanced Container Technologies Inc., a California corporation. As of February 28, 2022, ACTX is exploring the acquisition of the assets and the assumption of some or all of the liabilities of GP Solutions Inc., the developer and manufacturer of Grow Pods, for which ACTX is currently the sole U.S. distributor.

Because Grow Pods can be located almost anywhere, produce can be grown closer to the point of consumption and harvested at its peak, providing nutritious fruits and vegetables where needed. Indoor micro-farms, utilizing a practice known as vertical farming, have attracted the attention of governments and universities, which are now promoting vertical farming as a way to combat food insecurity and inequities.

The United States Department of Agriculture (USDA) has stated that vertical farming “is no longer a futuristic concept.” The department is enthusiastic about vertical farming, particularly those utilizing repurposed shipping containers, such as Grow Pods. Arizona State University reports that vertical farming reduces water use by 90 percent compared to conventional farming but produces 10 times the crop yield.

Products

Grow Pods

One of the company’s main business units is focused on selling advanced, self-contained hydroponic containers called Grow Pods. These unique and innovative automated systems are essentially micro-farms that can be placed virtually anywhere and, with their controlled and specially filtered environment, allow cultivation of a wide variety of crops, 365 days a year. The Grow Pod controlled environment offers major advantages for the production of high-value crops. The ability to grow year-round and the ability to cultivate in a smaller footprint using less water and power are some of the primary advantages of the system. Grow Pods offer constant temperature, humidity and airflow control, as well as automated watering and lighting schedules for optimal growth and minimal labor requirements, regardless of crop.

Containers

ACTX meets the needs of the pharmaceutical and medical markets, including the cannabis and hemp industries, with patented packaging systems. The company designs, customizes, brands and sells proprietary medical grade plastic containers that can store pharmaceuticals, herbs, teas and other solids or liquids, with a special built-in feature that can grind solids and shred herbs. The company’s flagship container product is the patented Medtainer®, a child resistant, medical-grade herb container and grinder that is water-tight, air-tight and smell proof. Packaging in the cannabis industry is critical, with numerous stringent regulations about how cannabis products must be packaged and labeled. ACTX also offers custom-branded, compliant vacuum seal bags and other retail container solutions.

Equipment and Supplies

ACTX markets and sells two principal products: Grow Pods, which are specially modified insulated shipping containers manufactured by GP Solutions Inc., in which plants, herbs and spices may be grown hydroponically in a controlled environment, and Medtainers®, which may be used to store pharmaceuticals, herbs, teas and other solids or liquids and can grind solids and shred herbs. The company also markets and sells various products related to Grow Pods and the Medtainer®, as well as providing private labeling and branding services for purchasers of Medtainers® and certain related products.

GP Solutions manufactures and sells other products, such as humidity controllers and LED lighting systems for vertical farming. The company’s specially designed lighting panels are programmed to emit the exact wavelength of light that each crop requires. The system has a daybreak-to-nightfall feature that gives plants the proper chromatic signals to grow rapidly and fruitfully. High efficiency LED light strips supply the crops with a red and blue light spectrum required for photosynthesis in the spectrum that plants need most.

Market Overview

The global vertical farming market is expected to reach $33.02 billion by 2030, according to a new report by Grand View Research. The market is forecast to expand at a CAGR of 25.5 percent from 2022 to 2030, according to Grand View. Escalating production of biopharmaceutical products, including cannabis, is anticipated to drive the market. The building-based segment of the market is expected to register a significant CAGR of 27.8 percent over the projected period. In addition, the climate control segment is expected to see high growth.

The global cannabis packaging market is expected to reach $14.34 billion by 2028, according to analysis by Reports and Data. The analysis forecasts 1,700 percent growth in cannabis users by the end of 2026, with packaging likely observing a whopping 26.42 percent growth in the forecast period. There are significant barriers to entry in the cannabis packaging market, giving an advantage to companies already established in the sector. These barriers include developing a thorough knowledge of the myriad regulations that govern cannabis packaging (which differ in each state), and child-resistance requirements.

Management Team

Douglas P. Heldoorn is the Founder and Chairman of Advanced Container Technologies Inc. He also holds the positions of President, CEO and COO at the company. Mr. Heldoorn has served on the Board of Directors since its inception in 2013. He has also previously held the position of Executive General Manager at Nissan Motor Corp.

Jeffory A. Carlson is CFO and Treasurer of ACTX. Mr. Carlson has also served as the company’s Corporate Controller since 2014.

Advanced Container Technologies Inc. (OTC: ACTX), closed Wednesday's trading session at $0.3, even for the day, on 3 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.073/$1.05.

Recent News

SideChannel Inc. (OTCQB: SDCH)

The QualityStocks Daily Newsletter would like to spotlight SideChannel Inc. (OTCQB: SDCH).

SideChannel Inc. (OTCQB:SDCH) announces total new annualizedrevenue for subscribers signed this fiscal year of $2.0 milliondollars. The provider of cybersecurity tools and services reportsan increasing number of clients that require an expanded servicedelivery team. To meet the demand, the firm continues to grow theteam of principal consultants, and is altering the structure of itsexecutive team to better serve its clients. Trent Bowling ispromoted to senior vice president of sales. David Chasteen, formerexecutive vice president of sales and marketing is moving away fromsales and marketing to serve the growing portfolio of clients. Theexecutive vice presidents, sales, and marketing all report directlyto the CEO. The new structure allows the company to cover moreground with the same resources in place.

SideChannel Inc. (OTCQB: SDCH) simplifies cybersecurity for mid-market companies by matching them with highly experienced information security officers at a cost lower than building an in-house information security team or hiring a full-time CISO.

SideChannel’s team of virtual Chief Information Security Officers (vCISOs) possesses a combined 400-plus years of experience in cybersecurity. They’ve honed their skills and abilities in places like Anthem, Dick’s Sporting Goods, Best Buy, TD Bank and the Pentagon. SideChannel lends this talent to clients, creating value in the form of a bespoke cybersecurity program perfectly sized for the growing enterprise.

SideChannel is committed to creating top-tier cybersecurity programs for SMBs to help them protect their data and assets. To date, SideChannel has created more than 50 multi-layered cybersecurity programs for its clients.

 

Reports show that cyberattacks on SMBs have increased in recent years, as organizations’ network attack surfaces have grown exponentially with remote and in-office workers increasingly relying on cloud environments, mobile devices, software applications and third-party suppliers to conduct business.

SideChannel continues expanding its service offerings, workforce and customer base, attracting over 20 virtual CISOs to serve across industries including fintech, biotech, healthcare, manufacturing, legal, defense and technology services. The company is based in Worcester, Massachusetts.

Market Opportunity

An analysis from ReportLinker states that the global cybersecurity market is expected to grow from an estimated value of $173.5 billion in 2022 to $266.2 billion by 2027, recording a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems, and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors driving cyber security market growth, according to the report.

A lack of cybersecurity professionals and the budget constraints among SMBs and start-ups in developing economies are expected to hinder market growth. Cybercriminals are using automated techniques to attack SMBs’ networks to take advantage of their weak security infrastructures. To save money, time and resources, SMBs are seeking cybersecurity solutions.

Enclave

Enclave expands upon SideChannel’s cybersecurity service offerings by solving a pervasive network security problem with a simple tool.

A comprehensive cloud and network security solution, Enclave enables IT teams to contain breaches faster, reduce network outages, minimize latency and strengthen overall security defense.

Enclave creates the foundation for a Zero Trust network security model IT can build upon.

With Enclave, IT can easily segment their company’s network, organize personnel and computing devices at the employee workload level, and implement security controls across all network segments.

Enclave was designed and purpose built to serve the growing security needs of SMBs, a traditionally underserved market that is more prone to cyberattacks but has limited protection due to smaller budgets, inadequate IT security staffing and a lack of cybersecurity awareness among top executives.

Enclave is an affordable and effective network security solution that shrinks the attack surface area exposed to a cyber intruder and significantly reduces the amount of effort required to operate securely.

Management Team

Brian Haugli is CEO of SideChannel. He has led programs for the U.S. Department of Defense, the Pentagon, and Fortune 500 companies. He is an expert on National Institute of Standards and Technology guidance, threat intelligence implementations and strategic organizational initiatives. He is a professor at Boston College, Woods College of Advancing Studies Master’s Program in Cybersecurity. He is also a contributing author for the Wiley book ‘Cybersecurity Risk Management’.

Ryan Polk is CFO at SideChannel. He has been the principal of Perissos Partners, an executive consulting firm, since June 2017. He also served in executive roles in the portfolio companies owned by Lacy Diversified, with combined revenue approaching $2 billion. He served as the Vice President for Corporate Financial Planning and Analysis for Brightpoint, a publicly traded, Fortune 500 mobile device logistics company. He earned a bachelor’s degree in accounting and industrial management from Purdue University.

Nicholas Hnatiw is Chief Technology Officer at SideChannel. Prior to joining the company, he served as the technical director for network operations supporting U.S. Cyber Command, U.S. Intelligence Agencies and other Department of Defense research organizations. He was also the CEO of Loki Labs, a cyber security firm. He earned a bachelor’s degree in computer engineering and computer science at the University of Massachusetts, Amherst.

Bill Roberts is SideChannel’s CISO. He most recently served as the vice president, IS & CISO for Hologic Inc., a global medical device company, where he established cyber security and IT compliance programs. Prior to Hologic, he was vice president of information security for Cytyc Corporation, which was acquired by Hologic in 2007. At Cytyc, he managed global IT as the company grew from 140 employees to 1,500 and from $40 million in revenue to over $750 million.

SideChannel Inc. (OTCQB: SDCH), closed Wednesday's trading session at $0.078, even for the day, on 37 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0402/$0.18.

Recent News

GeoSolar Technologies Inc.

The QualityStocks Daily Newsletter would like to spotlight GeoSolar Technologies Inc.

U.S. households generate over 40% of the nation’s greenhouse gasemissions, a result of being plugged into an electric grid whichstill derives most of its energy from fossil fuel-powered sources

A recent study has revealed that the world could save as much as$12 trillion by 2050 by switching from fossil fuels to renewableenergy – a claim predicated on the declining cost of renewableenergy generation

GeoSolar Technologies is looking to promote this energy transition,with its revolutionary SmartGreen(TM) Home system permittinghouseholds to slash their household utility bills to as little as$100 per annum whilst simultaneously, reducing their carbonfootprint

This is a view which is shared by GeoSolar Technologies (“GST”), a Colorado-based climate technology company pioneering anapproach into clean energy solutions for households. The Companyhas centered its corporate mission around reducing household carbonemissions through the introduction of its proprietarySmartGreen(TM) Home system. An environmentally friendly, renewableenergy-focused technology designed to harness energy from the earthand sun to power and purify homes and automobiles without the useof fossil fuels, the SmartGreen(TM) Home system has enabledhouseholds to both, reduce their carbon footprint to nearnegligible levels whilst slashing household utility bills to lessthan $100 per annum (https://ibn.fm/GWb2V).

GeoSolar Technologies Inc. (“GST”) is a Colorado-based climate technology company and the creator of the Smart Green Home® system for newly built and existing residences and commercial buildings. The company is focused on revolutionizing the way we heat, cool and power homes with 100% natural energy sources. Its patent-pending integrated system harnesses energy from the earth and sun to power and purify homes and automobiles without the use of fossil fuels.

In a GST home, the sun’s energy is captured on the roof to generate all of the electricity required. Additionally, the consistent climate of the earth is used to keep the home at a perfect temperature year-round, and the company’s proprietary air purifying unit ensures that the air inside the home is safe and healthy.

GST’s home technology has been installed in multiple test homes in Colorado and achieved exceptional results, including some of the most impressive energy efficiency ratings (HERS) in the industry.

GeoSolar Technologies is currently accepting investment as part of a Regulation A+ offering. Everyone* can invest now for as little as $300. For more information, visit the company’s profile on Manhattan Street Capital and review its Offering Circular.

GeoSolar Technologies Inc. (“GST”) has been qualified by the U.S. Securities and Exchange Commission (SEC) to conduct a Regulation A+ capital raise. GST is already a publicly traded company who makes quarterly and annual filings with the SEC and is subject to quarterly PCAOB audits. This is the first time shares of GeoSolar Technologies are being made available for public purchase. Upon completion of this Regulation A+ offering, the company intends to seek a listing of its stock.

 

The Decarbonization Movement

Soaring and unstable energy/fuel costs continue to highlight the importance of rethinking the traditional approach to powering homes, from top to bottom. While most everyone is well aware of the remarkable, multi-trillion-dollar opportunity the electric vehicle transformation offers to investors (in addition to the benefits to the climate problem), few recognize that the all-electric home market is as large as electric vehicles and equally important to reducing carbon emissions.

U.S. energy expenditures clocked in at $3,891 per person in 2018, leading to estimated spending of $1.3 trillion on energy that year alone. Despite this, fewer than 3% of U.S. homes are currently powered by solar. This number is poised to increase exponentially as both new and existing residences transition to zero carbon models.

GST estimates that if all the homes in America were powered by its technology, carbon pollution could be reduced by an estimated 1.9 trillion pounds per year, greatly reducing the negative impacts on our climate.

GeoSolarPlus®

The GeoSolarPlus (“GSP”) system combines solar power, geothermal ground-sourced energy and other clean energy technologies into one fully integrated system.
Key benefits of the GSP system include:

  • Making a real planet-changing difference in reducing air pollution
  • Eliminating or significantly reducing homeowners’ future utility bills
  • Enjoying lifetime energy independence and protection from price escalation and energy shortages
  • Eliminating greenhouse gas emissions from operation of home and daily life
  • Increasing home value
  • An integrated design for seamless operation of renewable energy systems
  • Maintaining a significantly healthier living environment
  • Leveraging existing renewable energy tax credits and electrification incentives
  • Creating stable jobs capable of supporting families in the decarbonized future

Click here to learn more about how GeoSolarPlus works.

Management Team

The GST leadership and management team includes some of the world’s most experienced and respected leaders in the fields of decarbonization and sustainable homes.

Stone Douglass is the Chairman and CEO of GST. He is a seasoned, 30-year public company executive and former Chairman and CEO of the Piper Aircraft Company.

Brent Mosbarger is the company’s Co-Founder and leads its commercial operations. He is a highly respected solar engineer whose experience includes roles with Chevron Energy’s green operations and serving as project manager and executive for a $400 million solar/geothermal innovation project.

Peter Romenesko is a Senior Strategic Advisor with GST. He brings to the company considerable experience as an engineer and large-scale project manager for Johnson Controls and Siemens.

Dr. Norbert Klebl is the company’s Co-Founder and Development Director. Recognized as one of the world’s leading experts in the field of zero-carbon innovation, he is a former McKinsey partner of 16 years with an MBA from Columbia.

Dar-Lon Chang is GST’s Director of New Product Development. Prior to joining GST, he had a 16-year career with ExxonMobil Energy Research. He received his PhD in engineering from the University of Illinois.

* Must be over 18, certain states are not currently available and will be added soon.


Recent News

chart

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF)

The QualityStocks Daily Newsletter would like to spotlight EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF).

Chase Edgelow, Co-Founder and CEO of EverGen Infrastructure wasfeatured in a recent Bell2Bell Podcast episode where he discussedthe company’s milestones achieved in 2022, such as public debut onthe OTCQX, $31m debt facility and expansion of core assetsportfolio, as well as operational plans for 2023

Company boasts liquidity that allows it to continue to buildinfrastructure assets out, grow and expand its team, and acceleratedevelopment projects in the space

EverGen’s business model based on low-risk, long-term contractedrecurring revenue positions the company in a unique place withinRNG – the space increasingly eyed by large-scale enterprises

"We've come a tremendous way in building out our platform over thelast 12 months. If you look at where we started from about 12months ago, we had three core assets. We now have five coreassets", said in a recent Bell2Bell Podcast episode Chase Edgelow,Co-Founder and CEO of EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF), Canada's renewable natural gas infrastructure platform. "And weraised a $31 million debt facility from a subsidiary of Scotiabankand Export Development Canada, which gives us liquidity to continueto build these infrastructure assets out and continue to grow andexpand our team and put our foot on some significant developmentprojects in the space", he continued.

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) is developing Canada’s Renewable Natural Gas Infrastructure Platform, starting on the west coast in British Columbia. The company is combating climate change and helping communities contribute to a sustainable future by acquiring, developing, building, owning and operating a portfolio of renewable natural gas (RNG), waste-to-energy, and related infrastructure projects.

While EverGen is currently focused on British Columbia, its continued growth is expected across other regions of North America. RNG is produced differently than conventional natural gas, without drilling wells. RNG is derived from biogas, which is captured from decomposing organic waste in landfills, food waste, agricultural waste matter and wastewater from treatment facilities. This waste feedstock is supplied to an anaerobic digester which contains bacteria that breaks down organic matter in the absence of oxygen. The resulting biogas is captured and cleaned to create carbon neutral or carbon negative RNG to be used by the existing North American gas pipeline grid. By capturing these emissions and transforming them into RNG, then combusting into CO2, the overall greenhouse gases (GHG) impact is materially less potent than allowing natural decomposition to release methane into the atmosphere. Liquid and solid digestate matter is a byproduct of the RNG production process and is used as fertilizer and in other applications.

EverGen operates three projects in British Columbia. The company was incorporated in 2020 and went public in 2021, with its common shares listed on the TSX Venture Exchange under ticker symbol ‘EVGN’. In February 2022, EverGen’s common shares began trading on the OTCQB Venture Market in the U.S. under ticker symbol ‘EVGIF’. The company is headquartered in Vancouver.

Portfolio Projects

Fraser Valley Biogas is one of three projects in EverGen’s portfolio. Located in Abbotsford, British Columbia, the facility has been digesting manure and off-farm organics since 2011 and was the first agricultural digester in Canada to produce RNG. The RNG generated through this project is part of a FortisBC program to supply renewable gas to homes, businesses and other customers. Fraser Valley Biogas also provides Abbotsford farms with renewable fertilizer via the digestate produced. EverGen acquired Fraser Valley Biogas early in 2021 and is currently enhancing and expanding the facility. These optimization projects resulted in record production during the month of September 2021, supporting the growing demand for RNG in British Columbia. Optimization activities contributed an additional 18% of RNG production for September and a 9% higher year-to-date production compared to the previous year. The facility produces approximately 80,000 gigajoules of RNG, enough to heat more than 1,000 homes for a year.

Net Zero Waste Abbotsford, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and RNG expansion project. The British Columbia Utilities Commission recently approved a 20-year offtake agreement between the facility and FortisBC, an electricity and gas utility. Under this agreement, FortisBC will purchase up to 173,000 gigajoules of RNG annually for injection into its natural gas system upon completion of an anaerobic digester project at Net Zero Waste Abbotsford. Once construction is complete, this project is expected to produce enough energy to meet the needs of more than 1,900 homes.

Sea to Sky Soils, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and potential future RNG expansion project which has been operating near Pemberton, British Columbia, on Lil’wat Nation land since 2012. The Lil’wat Nation is a key partner and supporter of the facility, which has employed a majority of its staff from the First Nation since inception. The Sea to Sky Soils facility processed approximately 160 percent of its forecast tonnage in the second half of 2021. In total, Sea to Sky Soils processed approximately 36,000 tons of organic waste in 2021. The facility is working with the Ministry of Environment to expand its operational capacity in 2022. EverGen has partnered with local municipalities – including Metro Vancouver and the municipality of Pemberton – for the delivery of additional organic waste to the facility. The facility is an important part of EverGen’s RNG infrastructure platform and serves as a source of valuable feedstock to support the company’s existing and future operations.

Market Outlook

A report from Global Market Insights states that the biogas market is projected to see significant growth over the next few years, driven by a shifting preference to utilize biogas to reduce emission levels from traditional fuels. Escalating RNG usage by gas utilities as a sustainable and low carbon alternative to supply heat and electricity in industries and buildings will further stimulate growth. RNG is increasingly deployed across the transport sector, especially for heavy vehicles and vessels, to abate GHG emissions.

Many North American gas utilities have set RNG targets of 5% to 15% of production by volume in 2030, compared to less than 1% by volume in 2020. FortisBC has a goal of including 15% RNG in its gas supply by 2030. EverGen believes this presents a potential C$16 billion+ opportunity for RNG producers.

Management Team

Chase Edgelow is co-founder and CEO at EverGen. He has over 15 years of specialized private investment, finance, and technical expertise in the energy and infrastructure sectors. His background is as a Facilities Engineer with Petro-Canada, independently managing energy infrastructure capital projects located in western Canada. He holds a Professional Engineer designation from the province of Alberta.

Mischa Zajtmann is co-founder and President at Evergen. He has 15 years of experience providing consulting and management for Canadian and American companies in the natural resources and energy space. He is a corporate securities lawyer who began his career at Blake, Cassels & Graydon LLP. His J.D. is from the University of Saskatchewan Law School. He’s a member of the British Columbia Bar.

Sean Mezei is COO at EverGen. He has 20 years of experience in the RNG industry, having served previously as the president of Greenlane Biogas and as a senior manager at QuestAir, and founder and president of Dekany Consulting. He was a co-chairman of the American Biogas Council’s RNG working group for six years. He has been a Registered Professional Engineer in the province of British Columbia since 1994.

Natasha Monk is CFO at EverGen. She is a CPA with 12 years accounting, financial reporting, and tax experience in public practice and industry. She is currently a partner at Affirm LLP, where she advises and consults to a wide variety of companies in multiple industries across public and private sectors. Prior to joining EverGen, she worked at KPMG. She graduated from the University of Calgary.

EverGen Infrastructure Corp. (OTCQX: EVGIF), closed Wednesday's trading session at $2.37, off by 4.0486%, on 200 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.365/$2.94.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

Scientists have determined that a drug derived from a certainnatural compound could help create a new way to treat glioblastoma,as observed in mouse models. Glioblastoma (glioblastoma multiforme) is an aggressive form of brain cancerthat invades brain tissue. The standard of care for this cancer isradiation, chemotherapy and surgery, which may alleviate somesymptoms but doesn’t halt the cancer. The average life expectancy following diagnosis is roughly 15 months. The study was a collaboration between different institutions, includingHarvard Medical School and Brown University. The compound inquestion, indirubin, is an active ingredient of Dang Gui Long Hui Wan, a plant mixture used to treat chronic illnesses in traditionalChinese medicine. Indirubin derivatives such as 6’-bromoindirubinacetoxime (BiA) have demonstrated potential in treating cancerthrough various mechanisms. The findings of this research, togetherwith the outcomes of other initiatives by for-profit companies suchas CNS Pharmaceuticals Inc. (NASDAQ: CNSP) could deliver better treatments to patients who currently havelimited effective options to fight brain cancer.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (http://nnw.fm/eDUjp).

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Wednesday's trading session at $1.7, off by 4.4944%, on 739,857 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.6105/$11.94.

Recent News

Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF)

The QualityStocks Daily Newsletter would like to spotlight Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF).

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF), a company working to advance the next generation of high qualitynickel-cobalt projects to feed the high growth electric vehicle andstainless steel markets, was featured in the latest episode of the Bell2Bell Podcast as part of IBN’s sustained effort to provide specialized content distribution viawidespread syndication channels. Mark Selby, the company’schairman, CEO and director, joined the program to discuss Canada Nickel’s leadership team, business model andoperating markets. “Canada Nickel Company was founded just overthree years ago. In that very short timeframe, we’ve taken aproject from drillhole to one of the largest nickel-sulfidediscoveries ever and the largest since the early 1970s,” Selbysaid. “The project is located just outside Timmins, which is a verywell-established mining camp. We have all the major infrastructureneeded to advance this project, and we’re about a third of the waythrough the permitting process already. We’re looking to bepermitted by the middle part of this decade, with first productionby 2027. Later this year, we’ll have our feasibility study out.We’re rapidly advancing this project, which will be one of thelargest nickel-sulfide mines globally.”

To view the full press release, visit https://ibn.fm/AK6NE

Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) is advancing the next generation of nickel-cobalt sulfide projects to deliver the metals needed to power the electric vehicle (EV) revolution and feed the high growth stainless steel market. The company is one of only a few new sources of potential supply outside Indonesia and China.

Canada Nickel possesses industry leading nickel expertise and is focused on low risk, well established mining jurisdictions. The company has launched wholly owned subsidiary NetZero Metals Inc. to develop zero-carbon production of nickel, cobalt and iron and has applied in multiple jurisdictions to trademark the terms NetZero Nickel, NetZero Cobalt and NetZero Iron. Canada Nickel is also pursuing development of processes to allow net zero carbon production of these elements.

Canada Nickel is currently anchored by its 100% owned flagship Crawford Nickel-Cobalt Sulfide Project with large-scale potential located in the heart of Ontario’s prolific Timmins-Cochrane mining camp, adjacent to major infrastructure.

The company believes the EV industry and many other consumer sectors have an urgent need for zero-carbon metal this decade, not in 20-25 years as contemplated by some resource companies. Canada Nickel also believes that nickel supplies from Indonesia and other Pacific island nations, typically controlled by Chinese-owned companies, are not the answer for batteries needed by GM, Ford and the European automakers working to develop and manufacture EV models.

The company is headquartered in Toronto.

Crawford Nickel-Cobalt Sulfide Project

The Crawford Nickel-Cobalt Sulfide Project is the largest sulfide discovery since the early 1970s and contains the fifth-largest nickel sulfide resource in the world, based on Measured & Indicated resources, according to the latest update. The Crawford project is expected to be one of the largest base metal mines in Canada based on results of a Preliminary Economic Assessment. Early projections by Canada Nickel estimate that the project has the potential to produce 50,000 tons of nickel per year. The company is now in the final stages of completing the project’s feasibility study.

The project is projected to produce 2.8 tons of CO2 per ton of nickel equivalent production, which is 89% lower than the industry average of 34 tons of CO2 per ton of nickel equivalent production.

The company is taking significant steps toward developing the Crawford project as a net zero carbon producer. In addition to harnessing the natural ability of the project’s geology to act as a carbon sink through spontaneous reaction of the host rock once exposed to atmospheric conditions called mineral carbonation, Canada Nickel has discovered a new way to enhance carbon capture, termed In Process Tailings (IPT) Carbonation. This act of conditioning the tailings with a concentrated stream of carbon dioxide before deposition has been demonstrated at lab scale to achieve carbon capture at a rate 8-12 times faster than naturally occurring sequestration, achieving more than 60% of the capture that had previously taken six days.

These latest results move the company further toward production of Net Zero Nickel™ and generation of 21 tonnes of CO2 credits per tonne of nickel, which would produce an estimated average of 710,000 tonnes of CO2 credits annually and 18 million total tonnes of CO2 credits over the expected life of mine. IPT Carbonation does not require complex new technologies and major process modifications and could encourage the development of a net zero carbon industrial cluster centered around the Crawford project.

Canada Nickel in January 2023 announced that its latest test work results support the incorporation of carbon capture and storage into the Crawford project. The company believes that utilization of existing process streams should allow IPT to be efficiently engineered and incorporated into the project’s flowsheet, with an integrated feasibility study for the project expected in the second quarter of 2023.

In December 2022, Canada Nickel announced its engagement on Deutsche Bank Securities Inc. (“Deutsche Bank”) and Scotiabank – two of the world’s leading investment banks with a broad base of mining and industrial expertise – as financial advisors for the equity component of the project financing for the Crawford project. In the same release, the company announced the completion of another significant permitting milestone by filing the detailed project description with the Impact Assessment Agency of Canada. Canada Nickel targets receipt of permits by mid-2025, with construction to immediately follow.

Additional Projects

The Reid Nickel Property is located just 16 kilometers southwest of Crawford, or 37 kilometers northwest of Timmins, and contains an ultramafic body with a target geophysical footprint of 3.9 square kilometers. Preliminary assay results from Canada Nickel’s summer/fall drilling program confirm the presence of mineralized dunite, as well as currently undefined higher-grade sections. Partial assay results confirm expected nickel grades. Nickel mineralization in serpentinized dunite was found in all 16 holes drilled to date.

The Sothman Nickel Property is located 70 kilometers south of Timmins. Five drill holes on the eastern half of the target anomaly confirmed the continuation of ultramafic lithologies, primarily peridotite, with moderate to strong serpentinization and variable amounts of mineralization throughout.

The company in December 2022 announced positive drilling results from its ongoing regional exploration campaign at its Reid and Sothman properties. These latest results continue to reinforce the success of Canada Nickel’s geophysical targeting approach and increase the probability of success at the company’s other 20-plus properties within its 42 square kilometers of geophysical targets.

Building on this momentum, Canada Nickel in December 2022 announced its entry into a deal to acquire a 100% interest in the past producing Texmont property situated between the company’s properties south of Timmins. As noted in the news release, the acquisition of the Texmont property provides near-term smaller scale production potential and is highly complementary to the company’s large-scale Crawford and regional nickel sulphide projects.

Market Opportunity

Global demand leaves the market fundamentally short of nickel in the medium- and long-term. Global primary nickel demand will likely reach 3 million tons in 2022, up from 2.4 million tons in 2020, according to the International Nickel Study Group (INSG).

The INSG says primary nickel production is forecast to hit 3.1 million tons in 2022. Indonesia, the world’s largest nickel miner, halted exports of unprocessed nickel ore in January 2020, due to a government-imposed ban. Indonesia has floated the concept of a nickel cartel whose member nations would exert influence over world nickel supply and prices, similar to OPEC’s pricing power over oil.

Benchmark Minerals, a leading EV supply chain research firm, projects that, by 2035, world demand for nickel will double from current levels to 6 million tons annually. That growing demand represents a need for new nickel production equivalent to 70 mines the size of Canada Nickel’s Crawford Project.

Management Team

Mark Selby is Chairman, CEO and Director of Canada Nickel. He was formerly President and CEO of RNC Minerals, where he led a team that successfully raised over $100 million and advanced the Dumont nickel-cobalt project from initial resource to a fully permitted, construction-ready project. He has held senior management roles with Quadra Mining, Inco and Purolator Courier, and was a partner at Mercer Management Consulting. Since 2001, he has been recognized as one of the leading authorities on the nickel market. He graduated from Queen’s University with a Bachelor of Commerce.

Wendy Kaufman is CFO of Canada Nickel. She has 25 years of experience leading publicly listed mining companies in project financing, capital structuring, capital markets, accounting and internal controls, tax, and financial reporting and public disclosure. She was also previously CFO at Khiron Life Sciences Corp. and held CFO and senior finance positions at Pasinex Resources Limited, Primero Mining Corporation and Inmet Mining Corporation. She holds a Bachelor of Business Administration from Wilfrid Laurier University and is a Chartered Professional Accountant.

Steve Balch is VP Exploration at Canada Nickel. He is an Ontario registered geoscientist with 32 years of experience in geophysics, specializing in magnetic and electromagnetic methods. He founded Triumph Instruments and developed the AirTEM system, a multi-coil helicopter-borne EM system that is in use worldwide. He has also been active in borehole geophysics and helped develop new technologies including north-seeking gyros, temperature compensated induction conductivity probes, UAV-based magnetometers and high sensitivity magnetic gradiometers.

Christian Brousseau is VP Capital Projects at Canada Nickel. He is a professional engineer (P.Eng) with over 30 years of experience in engineering, design and construction in the Canadian mining industry, including six years as Project Director for the Dumont Project and three years as the Engineering and Construction Manager for Detour Gold. Prior to Detour, he held various construction management positions at Osisko’s Malartic Project and at Goldcorp’s Éléonore Project. He also spent eight years at Falconbridge supervising and managing various capital projects.

Canada Nickel Company Inc. (OTCQX: CNIKF), closed Monday's trading session at $2.05, up 3.0151%, on 73,251 volume with 375 trades. The average volume for the last 3 months is 57,207 and the stock's 52-week low/high is $1.04999995/$5.63000011.

Recent News

Knightscope, Inc. (NASDAQ: KSCP)

The QualityStocks Daily Newsletter would like to spotlight Knightscope, Inc. (NASDAQ: KSCP).

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue lightemergency communication systems, has announced the site of its May9–11, 2023, Robot Roadshow “landing.” Jena Choctaw Pines Casino,located in Dry Prong, Louisiana, will host the three-day in-personevent, designed to be an experiential event to grab attention;forge direct connections with potential clients, investors and themedia; and strike up conversations about KSCP’s excitingtechnologies. The Louisiana stop will be the 80thlanding in 25states. To view the full press release, visit https://ibn.fm/zuTxZ

Knightscope, Inc. (NASDAQ: KSCP), founded in 2013 and based in Mountain View, California, is a leader in the development of autonomous security capabilities targeting to disrupt the $500 billion security industry. Knightscope’s technology uniquely combines self-driving technology, robotics, artificial intelligence and electric vehicles.

Knightscope designs and builds Autonomous Security Robots (ASRs) that provide 24/7/365 security to the places you live, work, visit and study. The company’s client list covers public institutions and commercial business operations, including multiple Fortune 1000 companies to date. These ASRs have been proven to enhance safety at hospitals, logistics facilities, manufacturing plants, schools and corporations. ASRs act as highly cost-effective complementary systems to traditional security and law enforcement officials, providing an additional advantage by continuing to offer uninterrupted patrolling capabilities across the country.

The company’s ASRs have assisted in the arrest of suspects involved in crimes ranging from armed robbery to hit-and-runs. Their machine-embedded thermal scanning capability even aided in preventing the breakout of a major fire. You can learn more about the crime fighting wins at www.knightscope.com/crime

The company has achieved several milestones since its creation in 2013, including:

  • Establishing itself in a 15,000-square-foot facility located in Mountain View, California, in the heart of Silicon Valley, where Knightscope designs, engineers and builds its technology (Made in the USA)
  • Operating for more than 1 million hours in the field and securing contracts across five time zones, from Hawaii to Rhode Island
  • Raising over $100 million since inception to build its technology from scratch and generating over $13 million in lifetime revenue, validating both the market opportunity and the technology

Growth Capital & Proposed Nasdaq Listing

With backing from more than 28,000 investors and four major corporations and over $100 million raised since inception, Knightscope is poised to be an industry leader in the future of public safety and security.

On December 1, 2021, Knightscope announced the commencement of an offering of up to $40 million of its Class A common stock, with shares to be listed immediately following closing on the Nasdaq Global Market under the ticker symbol ‘KSCP’. The offering is for up to 4 million shares priced at $10 per share. Learn more at www.knightscope.com/investors

Company Mission – Reimagining Public Safety

Knightscope’s long-term vision has an eye on the greater good. The company’s mission is to make the United States of America the safest nation in the world while supporting the 2+ million law enforcement and security professionals across the country.

Crime has an estimated negative economic impact in excess of $2 trillion annually. As crime is reduced, positive impacts will likely be realized across several aspects of society, including housing, financial markets, insurance, municipal budgets, local business and safety in general.

Knightscope CEO William Santana Li was interviewed by Kevin O’Leary, more commonly known as Shark Tank’s Mr. Wonderful. When asked to explain how the benefits provided by the ASRs outrank a human doing the same job, Li said, “First, just the simple presence of a physical deterrent causes criminal behavior to change. Second, the machines are self-driving cars that patrol all around and recharge themselves. They also generate 90 terabytes of data per year. No human would ever be able to process that. The robots are intended to be eyes and ears for the humans, not a one-to-one replacement.”

The Knightscope solution to reduce crime combines the physical presence of ASRs, sometimes referred to as proprietary Autonomous Data Machines, with real-time onsite data collection and analysis. The ASRs are fitted with eye-level 360° cameras, thermal scanning, public address announcements and various other features that work in tandem with humans to provide law enforcement officers and security guards unprecedented situational awareness.

Those 90 terabytes of data are then formatted in a useable way, so law enforcement can leverage that information and execute their responsibilities more effectively.

Public Safety Innovation

The company’s recurring revenue business model is set up to mimic the recurring societal problem of crime, and it takes into consideration the fact that innovation in the security and public safety industry has been stagnant for decades. Because the traditional practices of the sector have remained unchanged for years, automation has potential to drive substantial cost savings – and significant improvement in capabilities.

Human security guards are one of both the largest expenses and the largest liabilities for companies. Knightscope’s robots are offered at an effective price of $3 to $9 per hour, compared with approximately $85 for an armed off-duty law enforcement officer and $15 to $35 for an unarmed security guard.

This innovation has the potential to drive considerable cost savings. Based on these estimates, manufacturing costs can be recovered as soon as the first year of operation.

Product Offerings

The company has nine patents and a framework of unique intellectual property. Knightscope currently offers a K1 stationary machine, a K3 indoor machine and a K5 outdoor machine. A K7 multi-terrain four-wheel version is in development.

The ASRs autonomously patrol client sites without the need for remote control, providing a visible, force multiplying, physical security presence to help protect assets, monitor changes in the area and deter crime. The data is accessible through the Knightscope Security Operations Center (KSOC), an intuitive, browser-based interface that enables security professionals to review events generated by the ASRs providing effectively ‘mobile smart eyes and ears’. Learn more at www.knightscope.com/ksoc

The ASRs and the related technologies were developed ground up by the company and are Made in the USA.

The Robot Roadshow

Knightscope has created the ultimate hybrid physical and virtual event, bringing its Autonomous Security Robot technologies to cities across the country for interactive and in-person demonstrations.

Each roadshow landing is hosted virtually by a Knightscope expert, and visitors can interact directly with each of the company’s ASRs and see the Knightscope Security Operations Center (KSOC) user interface in action. Learn more at www.knightscope.com/roadshow

Management Team

Chief Executive Officer William Santana Li is a veteran entrepreneur, a former executive at Ford Motor Company and the founder of GreenLeaf, a company that grew to be the world’s second-largest automotive recycler and is now part of LKQ Corporation (NASDAQ: LKQ).

Chief Client Officer Stacy Dean Stephens brings his experience as a former Dallas law enforcement officer, as well as his skills as a seasoned entrepreneur, to assist on the client acquisition side.

Chief Intelligence Officer Mercedes Soria is an award-winning technologist and former Deloitte software engineer.

Chief Design Officer Aaron Lehnhardt brings over two decades of two- and three-dimensional product and industrial design in modeling and VR to the table, on top of his experience as a senior designer at Ford Motor Company.

Chief Financial Officer Mallorie Burke is a seasoned financial executive and strategic advisor for both private and publicly traded technology companies with a successful track record of mergers & acquisitions, corporate growth and exit strategies, including public listings.

General Counsel Peter Weinberg leverages 30 years of diverse corporate counsel experience, spanning from startups to well-established companies, private and public. He has significant experience training personnel at all levels in critical areas to improve corporate compliance and productivity.

Knightscope, Inc. (NASDAQ: KSCP), closed Wednesday's trading session at $0.58, off by 4.6836%, on 943,032 volume. The average volume for the last 3 months is 943,032 and the stock's 52-week low/high is $0.5534/$4.55.

Recent News

Cepton Inc. (NASDAQ: CPTN)

The QualityStocks Daily Newsletter would like to spotlight Cepton Inc. (NASDAQ: CPTN).

  • Cepton’s Helius® Smart Lidar System utilized by NITC-affiliatedresearchers from UTA in Texas-based studies since 2020
  • Collaboration enabled an innovative traffic signal solution inline with national Vision Zero and Complete Streets initiatives
  • Project currently under evaluation by UDOT for potentialexpansion in Utah, expected to mature

Cepton, Inc. (“Cepton”) (Nasdaq: CPTN), a leader in high performance lidar solutions for the automotive and smartinfrastructure markets , announced today that its lidar technology has been used ingroundbreaking studies in Texas and Utah to help improve trafficsafety for all road users, in alignment with the national Vision Zero and Complete Streets initiatives.

Cepton Inc. (NASDAQ: CPTN) is a provider of state-of-the-art, intelligent, lidar-based solutions serving a range of markets, including automotive (ADAS/AV), smart cities, smart spaces and smart industrial applications. General Motors (NYSE:GM) has granted a series production award for Cepton’s lidar, the biggest such award to date in the automotive space. Cepton’s is the lidar component of GM’s Ultra Cruise autonomous driving platform. By leveraging its patented Micro Motion Technology (MMT®) lidar platform, the company develops reliable, scalable and cost-effective solutions that deliver long-range, high-resolution 3D perception for smart applications.

Cepton was established in 2016 by co-founders Dr. Jun Pei and Dr. Mark McCord. The company is headquartered in San Jose, California, and serves a fast-growing customer base through an international presence spanning North America, Germany, Japan, India and China.

Micro Motion Technology (MMT®)

Cepton was built from the ground up to meet key lidar industry challenges for mass market adoption. This company’s portfolio of proprietary technology is uniquely aimed at facilitating this industry growth through a combination of performance, reliability, affordability and design integration.

Key among its innovations is MMT®, a mirrorless, frictionless, rotation-free 3D imaging platform designed specifically for lidars. Its benefits for OEMs and system integrators include:

  • Reliability – The durable design uses common, easily attainable materials.
  • Versatility – The platform is capable of achieving near- to ultra-long range with a wide field of view.
  • Efficiency – MMT® features a compact form factor, low power usage and inexpensive components.
  • Scalability – Its simple design means that scale-up to high manufacturing volumes is easily attainable.

Because of their compact form factor, Cepton lidars are embeddable and ideally suited for advanced driver-assistance system (ADAS) integration, whether behind windshield, in headlamp or in fascia.

Agreement with KOITO

KOITO Manufacturing Co. Ltd., the world’s premier Tier 1 auto lighting supplier, originally started an evaluation of Cepton’s MMT® based lidars in 2018. In 2020, KOITO made an investment in Cepton aimed at accelerating the company’s development and enabling KOITO’s industrialization of high-performance and high reliability lidar sensors for ADAS and autonomous vehicle (AV) applications.

Through this collaboration, Cepton was able to secure the largest ADAS lidar series production award[1] with General Motors as a sole source in the automotive space. The award covers GM vehicles for the initial period of 2023-2027.

On August 5, 2021, the two companies deepened their relationship when KOITO committed to invest a further $50 million in Cepton’s business through its participation in a Private Investment in Public Equity (PIPE) offering of shares of common stock of Growth Capital Acquisition Corp. in connection with Cepton’s recent merger.

Collaboration with GM

On July 13, 2021, Cepton announced that it had secured an ADAS lidar series production award from a leading, Detroit-based global automotive OEM – the biggest lidar production award by any OEM to any lidar company. It was later clarified that the OEM was General Motors, and Cepton’s lidar is part of GM’s ADAS Ultra Cruise system.

GM is “expected to deploy Cepton lidars in its next generation of advanced driver assistance systems (ADAS) across multiple vehicle classes and models – not just luxury cars.” As such, the agreement marks the potential for “an industry-first, mass-market adoption of lidar technology for automotive ADAS, with an anticipated deployment in consumer vehicles starting in 2023.”

On July 28, 2021, Ford Motor Company (NYSE: F) distributed an article on Medium noting, “Ford has been engaged with Cepton almost since their inception in 2016, both for R&D collaboration and small-scale deployments. Cepton LiDAR are deployed in some of [Ford’s] smart city projects. Based on Ford’s guidance, Cepton delivered a custom version of their LiDAR to enable R&D on advanced ADAS features.”

Market Outlook

Driven by increasing development and adoption in automobile safety applications, environmental mapping and 3D-modeling, the global lidar market is forecast to experience considerable growth over the coming years. A research report published by MarketsAndMarkets suggests that the sector will grow to an estimated $3.4 billion by 2026, achieving a CAGR of 21.6% over the next five years.

The report further highlights increasing investments in lidar startups by automotive giants as a driver of growth opportunities in the sector, particularly in North America.

In 2020, ground-based lidar accounted for the lion’s share of the overall lidar market, and this trend is expected to continue as the automotive sector continues to rapidly advance adoption across the full spectrum of vehicle classes. One factor not to be underestimated is the high barrier of entry and the exceptionally long time required for automotive OEMs to vet and award a production win to a lidar company. It is a commonly held view that the over 50 lidar companies will inevitably coalesce into a handful serving all OEMs.

Cepton, having a head start through its established partnership with leading global OEM GM, is uniquely positioned to capitalize on this market growth in the years to come.

Management Team

Cepton’s founder-led team is made up of lidar industry pioneers with decades of collective experience across advanced lidar and imaging technologies.

Jun Pei, Ph.D., is the company’s CEO and Co-Founder. He is a technology specialist with a focus in optics and electronics. Prior to founding Cepton, Dr. Pei founded AEP Technology, a firm focused on developing advanced 3D optical instruments. He received his Ph.D. in electrical engineering from Stanford University.

Mark McCord, Ph.D., is Cepton’s CTO and Co-Founder. Prior to founding Cepton, he led advanced development at KLA-Tencor. Dr. McCord also formerly served as an associate professor at Stanford University, where he earned his Ph.D. in electrical engineering.

Winston Fu, Ph.D., is the company’s CFO. Dr. Fu is the founder of Silicon Valley venture capital firm LDV Partners. Prior to joining Cepton, he served as CFO and Chairman of Active-Semi before its acquisition. Dr. Fu has also helped to build many technology companies as an entrepreneur and/or board member. He received his Ph.D. in applied physics from Stanford University, as well as an MBA from the Kellogg School of Management at Northwestern University.

[1] Largest known ADAS lidar series production award based on number of vehicle models awarded

Cepton Inc. (NASDAQ: CPTN), closed Wednesday's trading session at $0.3561, off by 9.3201%, on 5,340,805 volume. The average volume for the last 3 months is 5.341M and the stock's 52-week low/high is $0.3303/$3.10.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.